Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.17.19 - Carboxypeptidase Taq

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Logistic regression with a continuous exposure measured in pools and subject to errors.
Abscess
Chemokine patterns in children with acute bacterial infections.
Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V.
Acidosis
Acidic environment activates inflammatory programs in fibroblasts via a cAMP-MAPK pathway.
Acidosis differently modulates the inflammatory program in monocytes and macrophages.
Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human NT2-N neurons.
Extracellular Acidosis Regulates the Expression of Inflammatory Mediators in Rat Epithelial Cells.
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Acquired Immunodeficiency Syndrome
Biomarkers of HIV-1 CNS infection and injury.
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.
Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia.
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Reduction in monocyte chemoattractant protein-1 mRNA expression in peripheral blood mononuclear cells of diamorphine addicts.
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells.
[Chemokines as mediators for intercellular communication in the brain]
[Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients]
Acute Coronary Syndrome
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.
MCP-1 found to predict prognosis in acute and chronic phases after acute coronary syndrome.
Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Monocyte chemoattractant protein-1 in acute coronary syndromes: Complex vicious interaction.
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
[Change of serum MCP-1 level and CCR2 protein expression in isolated monocytes in patients with acute coronary syndrome.]
Acute Kidney Injury
A polymeric nanomedicine diminishes inflammatory events in renal tubular cells.
Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.
Exosomal ATF3 RNA Attenuates Pro-inflammatory Gene MCP-1 Transcription in Renal Ischemia-Reperfusion.
Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
MCP-1 gene activation marks acute kidney injury.
Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.
Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations.
Reversal Unilateral Ureteral Obstruction: A Mice Experimental Model.
Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.
Acute Lung Injury
Chemokine regulation of ozone-induced neutrophil and monocyte inflammation.
Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.
IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model.
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
IL-33-mediated IL-13 secretion by ST2+ Treg controls inflammation after lung injury.
Involvement of multiple transcription factors in regulation of IL-?-induced MCP-1 expression in alveolar type II epithelial cells.
[Effect of aging on pulmonary ICAM-1 and MCP-1 expressions in rats with lipopolysaccharide- induced acute lung injury.]
Acute-On-Chronic Liver Failure
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Adenocarcinoma
Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.
Adenocarcinoma of Lung
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.
Adenoma
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism.
Vitamin E delta-tocotrienol and metabolite 13'-carboxychromanol inhibit colitis-associated colon tumorigenesis and modulate gut microbiota in mice.
Adenomyosis
Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis.
Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window After Ovarian Stimulation.
Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis.
Impaired decidualization of human endometrial stromal cells from women with adenomyosis.
Aggressive Periodontitis
Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in patients with aggressive periodontitis.
AIDS Dementia Complex
Biomarkers of HIV-1 CNS infection and injury.
Airway Obstruction
The role of the beta chemokines in experimental obliterative bronchiolitis.
Albuminuria
2,3,5,4'-Tetrahydroxystilbene-2-O-?-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin.
Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats.
Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats.
Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Effects of Tumor Necrosis Factor-? on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy.
Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?
Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population.
Haploinsufficiency of the Transcription Factor Ets-1 Is Renoprotective in Dahl Salt-Sensitive Rats.
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-?B.
Lysyl oxidase like-2 contributes to renal fibrosis in Col4?3/Alport mice.
Monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-{beta}, increases podocyte motility and albumin permeability.
Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation.
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Oral administration of powdered dried rhizomes of Curcuma longa L. (turmeric, Zingiberaceae) is effective in the treatment of doxorubicin-induced kidney injury in rats.
Oral cholecalciferol decreases albuminuria and urinary TGF-?1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Smad3 mediates Ang II-induced hypertensive kidney disease in mice.
Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.
Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.
[Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus]
Alcoholic Neuropathy
Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies.
Alopecia Areata
Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in korean patients with alopecia areata.
Alveolar Bone Loss
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
Alveolitis, Extrinsic Allergic
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Experimental hypersensitivity pneumonitis: role of MCP-1.
Alzheimer Disease
Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly.
Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer's disease.
Elevated Plasma MCP-1 Concentration Following Traumatic Brain Injury as a Potential "Predisposition" Factor Associated with an Increased Risk for Subsequent Development of Alzheimer's Disease.
Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.
MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.
Role of MCP-1 and CCR2 in alcohol neurotoxicity.
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: A case-control study.
[Chemokines as mediators for intercellular communication in the brain]
Amyloidosis
MCP-1 as an Effector of IL-31 Signaling in Familial Primary Cutaneous Amyloidosis.
Amyotrophic Lateral Sclerosis
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Anaphylaxis
Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway.
MIP-1?, MCP-1, and desensitization in anaphylaxis from cow's milk.
Anemia
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib.
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.
Fermented goat milk consumption improves cardiovascular health during anemia recovery.
Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma.
Aneurysm
Altered patterns of gene expression distinguishing unruptured abdominal aortic aneurysms from ruptured ones: comprehensive analysis of inflammatory factors.
Cisternal CSF levels of cytokines after subarachnoid hemorrhage.
Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence.
Deficiency of ??T cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice.
Effects of stenting the parent artery on aneurysm filling and gene expression of various potential factors involved in healing of experimental aneurysms.
Expression of Pro-Inflammatory Cytokines and the Risk of Intracranial Aneurysm.
Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.
Local Delivery Is Critical for Monocyte Chemotactic Protein-1 Mediated Site-Specific Murine Aneurysm Healing.
Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls.
Monocyte Chemotactic Protein-1-Interleukin-6-Osteopontin Pathway of Intra-Aneurysmal Tissue Healing.
Roles of inflammation in the natural history of intracranial saccular aneurysms.
Aneurysm, Ruptured
Expression of Pro-Inflammatory Cytokines and the Risk of Intracranial Aneurysm.
Angina Pectoris
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
[Effect of compound paeonol dripping pill on levels of plasma inflammatory mediators in patients with unstable angina]
Angina, Stable
Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X?
Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina.
Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina.
Increased levels of monocyte-related cytokines in patients with unstable angina.
Inflammation and coronary artery disease.
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Monocyte chemoattractant protein-1 and coronary artery disease.
Plasma cytokines as predictors of coronary heart disease.
Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Angina, Unstable
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T.
Increased levels of monocyte-related cytokines in patients with unstable angina.
Inflammation and coronary artery disease.
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Monocyte chemoattractant protein-1 and coronary artery disease.
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
[Markers of inflammation--monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein--in blood of patients with unstable angina pectoris and stable effort angina]
Anthracosis
MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis.
Anti-Glomerular Basement Membrane Disease
Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Antiphospholipid Syndrome
Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells.
Aortic Aneurysm
A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury.
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.
High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model.
MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats.
Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.
Aortic Aneurysm, Abdominal
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.
Interleukin-10 promotes proliferation of vascular smooth muscle cells by inhibiting inflammation in rabbit abdominal aortic aneurysm.
Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm.
Appendicitis
Evaluation of a Possible Inflammatory Response after Appendectomy for Non-Perforated Appendicitis in Children.
Arterial Occlusive Diseases
Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery--a pilot study.
Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Arteriosclerosis
Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis.
Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.
Effects of a healthy life exercise program on arteriosclerosis adhesion molecules in elderly obese women.
Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.
Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression.
Histamine receptors expressed in circulating progenitor cells have reciprocal actions in ligation-induced arteriosclerosis.
Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
Arteriovenous Fistula
MCP-1 contributes to arteriovenous fistula failure.
Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.
Arteritis
MCP-1 gene haplotype association in biopsy proven giant cell arteritis.
Arthralgia
Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand.
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Arthritis
A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide-induced inflammatory responses, depending on its capacity to induce the unfolded protein response.
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model.
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel Fc?RIIB-deficient rheumatoid arthritis mouse model.
Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1.
Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis.
Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis.
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Novel Compound Q-1 Alleviates Type II Collagen-Induced Arthritis in Rats through the NF-?B Pathway.
Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8.
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls.
Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1.
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese.
The immunobiology of viral arthritides.
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis.
The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats.
Triptolide inhibits CC chemokines expressed in rat adjuvant-induced arthritis.
Arthritis, Experimental
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Effect of galantamine on adjuvant-induced arthritis in rats.
Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1.
[Effect of tongbiling on the expression of MCP-1 mRNA of synovial cells in rats with adjuvant arthritis]
Arthritis, Gouty
N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.
Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation.
Arthritis, Juvenile
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis.
Arthritis, Rheumatoid
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Anti-arthritogenic effect of Saponin-1 by alteration of Th1/Th2 cytokine paradigm in arthritic mice.
Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
Blockade of IL-6 and TNF-? inhibited oxLDL-induced production of MCP-1 via scavenger receptor induction.
Development of protein microarray technology to monitor biomarkers of rheumatoid arthritis disease.
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice.
Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis.
Expression of IFN-inducible protein-10 in chronic hepatitis.
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis.
Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production.
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Macrophages - silent enemies in juvenile idiopathic arthritis.
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.
MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis.
MCP-1: Function, regulation, and involvement in disease.
miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis.
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis.
Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8.
Targeting monocyte chemoattractant protein-1 signalling in disease.
The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.
[Effect of tongbiling on the expression of MCP-1 mRNA of synovial cells in rats with adjuvant arthritis]
[Expression of monocyte chemoattractant protein-1 and lupus nephritis]
Aspergillosis
Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis.
Asthma
A shotgun proteomic approach reveals novel potential salivary protein biomarkers for asthma.
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.
Association between MCP-1 -2518A>G polymorphism and asthma susceptibility: a meta-analysis.
Biflavonoid-rich fraction from Daphne pseudomezereum var. koreana Hamaya exerts anti-inflammatory effect in an experimental animal model of allergic asthma.
Bulleyaconitine A Effectively Relieves Allergic Lung Inflammation in a Murine Asthmatic Model.
Ciclesonide Inhibits TNF? and IL-1? Induced Monocyte Chemotactic Protein-1 (MCP-1/ CCL2) Secretion from Human Airway Smooth Muscle Cells.
Differential association of plasma monocyte chemoattractant protein-1 with systemic inflammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthma.
Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma.
Expression of adhesion molecules on granulocytes and monocytes from patients with asthma stimulated in vitro with interleukin-8 and monocyte chemotactic protein-1.
Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma.
Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects.
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
Intelectin is required for IL-13-induced monocyte chemotactic protein-1 and -3 expression in lung epithelial cells and promotes allergic airway inflammation.
Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
MCP-1 and RANTES are mediators of acute and chronic inflammation.
MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma.
MCP-1, CCR2 and CCR5 Polymorphisms in Tunisian Patients with Atopic Asthma.
Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Nasal lavage VEGF and TNF-? levels during a natural cold predict asthma exacerbations.
Pediatric asthmatic patients have low serum levels of monocyte chemoattractant protein-1.
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity.
Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors.
Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics.
Recruited Alveolar Macrophages, in Response to Airway Epithelial-derived MCP-1/CCL2, Regulate Airway Inflammation and Remodeling in Allergic Asthma.
Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge.
Selected CC and CXC chemokines in children with atopic asthma.
Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children.
Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma.
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.
Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
Zinc Suppressed the Airway Inflammation in Asthmatic Rats: Effects of Zinc on Generation of Eotaxin, MCP-1, IL-8, IL-4, and IFN-?
[Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease]
Astrocytoma
CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.
Cytokine regulation of CC and CXC chemokine expression by human astrocytes.
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.
Molecular cloning of the MCP-3 chemokine gene and regulation of its expression.
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Suppression of methylmercury-induced IL-6 and MCP-1 expressions by N-acetylcysteine in U-87MG human astrocytoma cells.
The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP.
Asymptomatic Infections
Cerebrospinal fluid markers that predict SIV CNS disease.
In situ cytokines (IL-4, IL-10, IL-12, IFN-?) and chemokines (MCP-1, MIP-1?) gene expression in human Leishmania (Leishmania) Mexicana infection.
Atherosclerosis
17beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells.
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
A Causal Relationship between Shear Stress and Atherosclerotic Lesions in Apolipoprotein-E Knockout Mice Assessed by Ultrasound Biomicroscopy.
A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.
ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages.
Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis.
Acute-Phase Inflammatory Response to Single-Bout HIIT and Endurance Training: A Comparative Study.
Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells.
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.
Anti-atherogenic effect of San-Huang-Xie-Xin-Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells.
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Arctium lappa root extract containing L-arginine prevents TNF-?-induced early atherosclerosis in vitro and in vivo.
Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines.
Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells.
Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits.
c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells.
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells.
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
CCR2 deficiency decreases intimal hyperplasia after arterial injury.
Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
Characterization of Monocyte Chemoattractant Proteins and CC Chemokine Receptor 2 Expression During Atherogenesis in Apolipoprotein E-null Mice.
Chemokines and atherosclerosis.
Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells.
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction.
Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation.
Corosolic Acid Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Regulating the Nuclear Factor-?B Signaling Pathway and Inhibiting Monocyte Chemoattractant Protein-1 Expression.
Curcumin incorporated titanium dioxide nanoparticles as MRI contrasting agent for early diagnosis of atherosclerosis- rat model.
Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling.
Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells.
Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients.
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
D-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs.
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.
Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study.
Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression.
Disparity of MCP-1 mRNA and protein expressions between the carotid artery and the aorta in WHHL rabbits: one aspect involved in the regional difference in atherosclerosis.
Effect of olmesartan medoxomil on atherosclerosis: clinical implications of the emerging evidence.
Effect of PKC-? Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).
Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.
Effects of antiatherosclerosis in carotid artery by RNAi-mediated silencing of MCP-1 expression.
Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice.
Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits.
Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys.
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.
Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease.
ERK is integral to the IFN-?-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages.
Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.
Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.
Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis.
Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells.
Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
Expression of monocyte chemoattractant protein-1 by nonenzymatically glycated albumin (Amadori adducts) in vascular smooth muscle cells.
Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.
Expression of monocyte chemoattractant protein-1 in monocytes and effects of native and oxidized very low density lipoproteins.
Expression of monocyte chemoattractant protein-1 in vascular tissue.
Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty.
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein.
Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice.
Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades.
High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1.
Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.
Housefly Maggots (Musca domestica) Protein-enriched Fraction/ extracts (PE) Inhibit Lipopolysaccharide-induced Atherosclerosis Pro-inflammatory Responses.
Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-?B/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Impact of MCP-1 in atherosclerosis.
Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme.
Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells.
Inflammation and enhanced atherogenesis in the carotid artery with altered blood flow in an atherosclerosis-resistant mouse strain.
Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
Inhibition of monocyte chemotactic protein-1 synthesis by statins.
Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells.
Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production.
Interferon-gamma-induced apoptosis and activation of THP-1 macrophages.
Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma.
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.
Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse.
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Lower macrophage recruitment and atherosclerosis resistance in FVB mice.
Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
Macrophage Adipose Triglyceride Lipase Deficiency Attenuates Atherosclerotic Lesion Development in Low-Density Lipoprotein Receptor Knockout Mice.
Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis.
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease.
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma.
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
MCP-1: chemoattractant with a role beyond immunity: a review.
Metabolic Syndrome Is Associated with Increased Plasma Levels of Monocyte Chemoattractant Protein in Dialysis Patients.
Modulation of atherogenesis by chemokines.
Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.
Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.
Monocyte chemoattractant protein-1 and coronary artery disease.
Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions.
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis.
Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats.
Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages.
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells.
Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice.
Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes.
Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome.
Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits.
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis.
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.
No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls.
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure.
Overexpressed miR-335-5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome.
Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages.
p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-?B p65 in human vascular smooth muscle cells.
p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.
Pathobiology of atherosclerosis--a brief review.
Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice.
Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Platelet-derived growth factor-specific regulation of the JE promoter in rat aortic smooth muscle cells.
Polymeric Vector-Mediated Targeted Delivery of Anti-PAK1 siRNA to Macrophages for Efficient Atherosclerosis Treatment.
Predicting carotid restenosis by comparison of plaque MCP-1 mRNA expression and serum levels.
Predictive Markers of Blood Cytokine and Chemokine in Recurrent Brain Infarction.
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Quercetin attenuates Monocyte Chemoattractant Protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1.
Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.
Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages.
Role of mast cells in atherosclerosis: a classical inflammatory disease.
Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.
Sublingual Vaccine with GroEL Attenuates Atherosclerosis.
Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.
Targeting MCP-1 to reduce vascular complications of obesity.
The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients.
The effect of n-3 fatty acids on coronary atherosclerosis: results from SCIMO, an angiographic study, background and implications.
The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway.
The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis.
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.
The potential role of resistin in atherogenesis.
The role of MCP-1 in atherosclerosis.
Thioredoxin 1 downregulates MCP-1 secretion and expression in human endothelial cells by suppressing nuclear translocation of activator protein 1 and redox factor-1.
Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-?B signaling pathway activation in vascular endothelial cells.
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.
TLR4/NF-?B signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.
Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis.
Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages.
Ultravist Induces the Expression of MCP-1 and VCAM-1 in IL-4-Stimulated HUVECs.
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.
Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice.
Whitmania Pigra Whitman Extracts Inhibit Lipopolysaccharide Induced Rat Vascular Smooth Muscle Cells Migration and their Adhesion Ability to THP-1 and RAW 264.7 Cells.
[Aortic expression of monocyte chemotactic protein-1 (MCP-1) gene in rabbits with experimental atherosclerosis]
[Contribution of monocyte chemoattractant protein-1 and c-fms/macrophage colony-stimulating factor receptor to coronary artery disease: analysis of human coronary atherectomy specimens]
[Effect and mechanism of gypenosides on the inflammatory molecular expression in high-fat induced atherosclerosis rats]
[Effect of selenium on expression of P38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 in diabetic endothelial cells.]
[Effects of dry red wine on experimental atherosclerosis in rabbits]
[Effects of IL-1beta, TNF-alpha and lipopolysaccharide on the expression of MCP-1 in human umbilical vein endothelial cells]
[Effects of oxidatively modified low density lipoprotein and very low density lipoprotein on the expression of MCP-1 in macrophages]
[Expression of monocyte chemoattractant protein-1 in aorta of early hypertensive rats]
[Inhibition of monocytes adhesion to the intima of arterial wall by local expression of antisense monocyte chemotactic protein-1]
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
Atrial Fibrillation
Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
Autoimmune Diseases
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Chemokine production by rat myocytes exposed to interferon-gamma.
Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia.
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.
Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.
Azotemia
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Bacteremia
Transcriptional regulation of alpha5beta1 integrin, fibronectin, VCAM-1, MCSF-1/c-fms, and MCP-1 in atrioventricular valves after valvular surgery and Staphylococcus aureus bacteremia.
Bacterial Infections
Cytokines and chemokines as biomarkers of community-acquired bacterial infection.
Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling.
Monocyte chemoattractant protein-1 expression by osteoblasts following infection with Staphylococcus aureus or Salmonella.
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection.
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Behcet Syndrome
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Biliary Atresia
Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Blister
Impaired monocyte CD11b expression in interstitial inflammation in hemodialysis patients.
Inhibition of Monocyte Chemoattractant Protein 1 Prevents Conjunctival Fibrosis in an Experimental Model of Glaucoma Filtration Surgery.
Leukocyte CD11b and CD62l expression in response to interstitial inflammation in CAPD patients.
Monocyte adhesion molecule expression in interstitial inflammation in patients with renal failure.
Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.
Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production.
The Science of Glaucoma Surgery -Filtration Surgery and the Role of Cytokines.
Bone Diseases
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease.
Bone Diseases, Metabolic
MCP-1 and CCR2 Gene Variants and the Risk for Osteoporosis and Osteopenia.
Bone Neoplasms
Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.
MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain.
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.
Bone Resorption
Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
Regulation and enzymatic basis of bone resorption by human osteoclasts.
Smoking Dependent Alterations in Bone Formation and Inflammation Represent Major Risk Factors for Complications Following Total Joint Arthroplasty.
Borna Disease
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Brain Abscess
Association of ICAM-1 (K469E) and MCP-1 -2518 A>G gene polymorphism with brain abscess.
Brain Death
Brain death in combination with warm ischemic stress during isolation procedures induces the expression of crucial inflammatory mediators in the isolated islets.
Donor Brain Death Predisposes Human Kidney Grafts to a Proinflammatory Reaction after Transplantation.
Multiorgan procurement increases systemic inflammation in brain dead donors.
Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death.
Time-dependent changes in donor brain death related processes.
Brain Diseases
Blood Biomarkers and 6- to 7-Year Childhood Outcomes Following Neonatal Encephalopathy.
MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice.
The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1.
Brain Edema
Experimental studies of erythropoietin protection following traumatic brain injury in rats.
Brain Infarction
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Predictive Markers of Blood Cytokine and Chemokine in Recurrent Brain Infarction.
Brain Injuries
Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain.
Albumin stimulates monocyte chemotactic protein-1 expression in rat embryonic mixed brain cells.
Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme.
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain.
Chemokines direct neural progenitor cell migration following striatal cell loss.
IL-5; a diffuse biomarker associated with brain inflammation after blast exposure.
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.
Brain Injuries, Traumatic
BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury.
Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides.
Elevated Plasma MCP-1 Concentration Following Traumatic Brain Injury as a Potential "Predisposition" Factor Associated with an Increased Risk for Subsequent Development of Alzheimer's Disease.
Experimental studies of erythropoietin protection following traumatic brain injury in rats.
Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques.
Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury.
The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat.
Brain Ischemia
Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats.
Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats.
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice.
Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat.
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
MCP-1 mediated activation of microglia promotes white matter lesions and cognitive deficits by chronic cerebral hypoperfusion in mice.
Monocyte chemoattractant protein-1-deficiency results in altered blood-brain barrier breakdown after experimental stroke.
Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression.
Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia.
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.
[Angiogenesis mechanisms in the formation of structural changes of brain tissue in patients with progressive cerebrovascular disease].
[Influence of JDTL injection on inflammatory factors in rat experimental cerebral ischemia]
Brain Neoplasms
Experimental gliosarcoma induces chemokine receptor expression in rat brain.
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1.
Breast Diseases
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Breast Neoplasms
A systematic review and meta-analysis of the effects of general anesthesia combined with continuous paravertebral block in breast cancer surgery and postoperative analgesia.
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India.
Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Biological ageing and frailty markers in breast cancer patients.
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.
CD16(+) monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Effects of protein kinase Cdelta and phospholipase C-gamma1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death.
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma.
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization.
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Lymph cytokines as markers oncogenesis and effective treatment of experimental breast cancer Wistar rat.
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
MCP-1-induced ERK/GSK-3?/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Metastatic breast cancer induces an osteoblast inflammatory response.
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.
Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ER? via PI3K/Akt/mTOR signaling.
Oestrogen receptor negative breast cancers exhibit high cytokine content.
Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study.
Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-?1.
PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells.
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.
Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.
Bronchiolitis
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Bronchitis, Chronic
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics.
Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Bronchopneumonia
Deoxynivalenol exacerbates viral bronchopneumonia induced by respiratory reovirus infection.
Brucellosis
Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
Candidemia
Integrating GWAS with bulk and single-cell RNA-sequencing reveals a role for LY86 in the anti-Candida host response.
carboxypeptidase taq deficiency
Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation.
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism.
Diminished induction of skin fibrosis in mice with MCP-1 deficiency.
Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA.
Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet.
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.
MCP-1 contributes to arteriovenous fistula failure.
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration.
MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.
MCP-1 deficiency enhances browning of adipose tissue via increased M2 polarization.
MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model.
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset.
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis.
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Carcinogenesis
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1? and VEGF.
Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice.
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
MCP-1-induced ERK/GSK-3?/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Whole body microwave irradiation for improved dacarbazine therapeutical action in cutaneous melanoma mouse model.
Carcinoma
Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus.
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain.
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas.
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Monocyte chemoattractant protein-1 is generated via TGF-beta by myofibroblasts in gastric intestinal metaplasia and carcinoma without H. pylori infection.
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma.
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Studies on the Bioactive Flavonoids Isolated from Pithecellobium clypearia Benth.
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Tumor-driven matrix invasion by infiltrating lymphocytes: involvement of the alpha1 integrin I-domain.
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
Carcinoma in Situ
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Carcinoma, Basal Cell
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Carcinoma, Ductal
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Carcinoma, Hepatocellular
Cachexia--induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease.
Expression patterns of cytokines and chemokines genes in human hepatoma cells.
Hepatocyte-specific hypoxia-inducible factor-1? is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.
Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.
Oxidative products from alcohol metabolism differentially modulate pro-inflammatory cytokine expression in Kupffer cells and hepatocytes.
Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.
Carcinoma, Intraductal, Noninfiltrating
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Carcinoma, Lewis Lung
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Carcinoma, Non-Small-Cell Lung
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Carcinoma, Ovarian Epithelial
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Carcinoma, Renal Cell
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma.
Tumor-driven matrix invasion by infiltrating lymphocytes: involvement of the alpha1 integrin I-domain.
[Polymorphisms in inflammatory response genes in metastatic renal cancer]
Carcinoma, Squamous Cell
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
Cardiomegaly
Angiotensin ? Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage.
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Cardiomyopathies
Abrogation of cardiomyopathy in diabetic rats by escin - possible role of NF-?? and MCP-1.
Chemokines and cardiac fibrosis.
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia.
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Pegfilgrastim and linagliptin potentiate chemoattraction of Ccr2 and Cd44 stem cells accompanied by alterations of cardiac Hgf, Igf-1 and Mcp-1 in daunorubicin cardiomyopathy.
Cardiomyopathy, Dilated
Expression of leukocyte chemotactic cytokines in myocardial tissue.
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.
Cardiotoxicity
Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.
Cardiovascular Diseases
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes.
Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.
Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects.
Effects of intermittent exercise on biomarkers of cardiovascular risk in night shift workers.
Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Femoral artery diameter and arteriogenic cytokines in healthy women.
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Impact of chronic wounds of various etiology on systemic profiles of key inflammatory cytokines, chemokines, and growth factors and their interplay.
Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol.
MCP-1-induced protein promotes endothelial-like and angiogenic properties in human bone marrow monocytic cells.
MCP-1: Function, regulation, and involvement in disease.
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Serum levels of cytokines and chemokines associated with cardiovascular disease in Brazilian patients treated with statins for dyslipidemia.
Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness.
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
[Prospects of buccal epithelium application for noninvasive diagnosis of coronary heart disease in people of different age.]
[The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases]
Carotid Artery Diseases
Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease.
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness.
Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan.
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Carotid Stenosis
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation.
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Cataract
Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery.
Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.
Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
Characteristic Profiles of Inflammatory Cytokines in the Aqueous Humor of Glaucomatous Eyes.
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients.
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Dynamic monocyte chemoattractant protein-1 level as predictors of perceived pain during first and second phacoemulsification eye surgeries in patients with bilateral cataract.
Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation.
Inflammatory cytokine profiles in eyes with primary angle-closure glaucoma.
Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification.
Molecular Inflammation in the Contralateral Eye After Cataract Surgery in the First Eye.
Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.
Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.
The high expression of the pain-related inflammatory factors in the eyes of cataract patients infected with hepatitis B virus.
cathepsin e deficiency
Differential regulation of the nature and functions of dendritic cells and macrophages by cathepsin e.
Central Nervous System Diseases
Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
Cerebrospinal fluid markers that predict SIV CNS disease.
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.
Central Nervous System Infections
Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
ceramidase deficiency
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
Cerebral Hemorrhage
Gene silencing of MCP-1 prevents microglial activation and inflammatory injury after intracerebral hemorrhage.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Cerebral Infarction
Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction.
Correlations of MCP-1 -2518A>G Polymorphism and Serum Levels with Cerebral Infarction Risk: A Meta-Analysis.
IL-27 Protects the Brain from Ischemia-Reperfusion Injury via the gp130/STAT3 Signaling Pathway.
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
Cerebrovascular Disorders
Effect of dietary ? carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E(-/-) mice.
High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
Cervical Intraepithelial Neoplasia
In situ increased chemokine expression in human cervical intraepithelial neoplasia.
Chagas Disease
alpha 4 Integrins and sialyl Lewis x modulation in chronic Chagas disease: further evidence of persistent immune activation.
Chikungunya Fever
High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand.
Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells.
Cholangitis
Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver.
Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats.
Cholangitis, Sclerosing
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Cholera
Migration responses of human monocytic cell lines to alpha- and beta-chemokines.
Migratory Response of Human NK Cells to Monocyte-Chemotactic Proteins
Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.
Transcriptional upregulation of inflammatory cytokines in human intestinal epithelial cells following Vibrio cholerae infection.
Cholestasis
Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats.
The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Chorioamnionitis
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Pulmonary and systemic expression of monocyte chemotactic proteins in preterm sheep fetuses exposed to lipopolysaccharide-induced chorioamnionitis.
Pulmonary and Systemic Expression of Monocyte Chemotactic Proteins in Preterm Sheep Fetuses Exposed to LPS Induced Chorioamnionitis.
Choroidal Neovascularization
Magnetic nanoparticles conjugated with "RPE cell -MCP-1 antibody -VEGF antibody" compounds for the targeted therapy of age-related macular degeneration: a hypothesis.
The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid ? Induced Production of Angiogenic Factors b y ARPE-19 Cells.
Chronic Periodontitis
Association between Monocyte Chemoattractant Protein-1 -2518 (A/G) Single Nucleotide Polymorphism and Chronic Periodontitis in End-stage Renal Disease Patients - A Case-control Study.
Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease.
[Infiltration of monocytes/macrophages and expression of monocyte chemoattractant protein-1 in gingival tissues from patients with rapidly progressive periodontitis]
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Chronic Urticaria
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
Coinfection
Events associated with susceptibility to invasive Salmonella enterica serovar Typhi in BALB/c mice previously infected with Plasmodium berghei ANKA.
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment.
Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response.
Serum cytokine responses in Rickettsia felis infected febrile children, Ghana.
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Colic
Infantile Colic is Associated with Low-grade Systemic Inflammation.
Colitis
CD40 Receptor Knockout Protects against Microcystin-LR (MC-LR) Prolongation and Exacerbation of Dextran Sulfate Sodium (DSS)-Induced Colitis.
Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells.
Chrysin Ameliorates Chemically Induced Colitis in the Mouse Through Modulation of a PXR/NF-?B Signaling Pathway.
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells.
Dietary Nondigestible Polysaccharides Ameliorate Colitis by Improving Gut Microbiota and CD4+ Differentiation, as Well as Facilitating M2 Macrophage Polarization.
Early detection of renal injury using urinary vanin-1 in rats with experimental colitis.
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis.
Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset.
Monocyte chemotactic protein-1 in a randomized placebo controlled study of canine plasmacytic-lymphocytic colitis.
Sacral nerve stimulation improves colonic inflammation mediated by autonomic-inflammatory cytokine mechanism in rats.
Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.
Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1? expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice.
TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity.
The anti-inflammatory activity of peptides from simulated gastrointestinal digestion of preserved egg white in DSS-induced mouse colitis.
The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis.
The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats.
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
[CD226 knockout aggravates radiation-induced liver injury in mice].
Colitis, Microscopic
Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers.
Colitis, Ulcerative
Chemokines in the inflammatory bowel diseases.
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Systemic Inflammation in Preclinical Ulcerative Colitis.
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
[rCsHscB derived from Clonorchis sinensis has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice].
Colitis-Associated Neoplasms
Vitamin E delta-tocotrienol and metabolite 13'-carboxychromanol inhibit colitis-associated colon tumorigenesis and modulate gut microbiota in mice.
Colonic Neoplasms
Differential Expression of mRNA in Human Monocytes following Interaction with Human Colon Cancer Cells.
Expression of chemotaxis- and angiogenesis-related factors in human monocytes following interaction with colon cancer cells is suppressed by low-dose lipopolysaccharide.
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
[Perioperative immunologic changes in colorectal cancer patients].
Colorectal Neoplasms
An association of the MCP-1 and CCR2 single nucleotide polymorphisms with colorectal cancer prevalence.
Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines.
Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.
Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells.
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
Coma
Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms.
Communicable Diseases
Reduction in monocyte chemoattractant protein-1 mRNA expression in peripheral blood mononuclear cells of diamorphine addicts.
Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden.
Conjunctivitis, Allergic
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments.
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
MCP-1, CCR2 and CCR5 Polymorphisms in Tunisian Patients with Atopic Asthma.
Contracture
FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice.
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Corneal Dystrophies, Hereditary
Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet's Stripping Automated Endothelial Keratoplasty.
Corneal Neovascularization
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Involvement of macrophage chemotactic protein-1 and interleukin-1beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea.
Coronary Aneurysm
Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease.
Coronary Artery Disease
A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation.
A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population.
Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervension in patients with coronary artery disease.
Association between Plasma Monocyte Chemoattractant Protein-1 Levels and the Extent of Atherosclerotic Peripheral Artery Disease.
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Correlation between IL-7 and MCP-1 in diabetic chronic non healing ulcer patients at higher risk of coronary artery disease.
Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease.
Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-?B, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.
Elevated circulating levels of C-C chemokines in patients with congestive heart failure.
Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
IL-17 contributes to the development of chronic rejection in a murine heart transplant model.
Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.
Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis - Influence on IP-10, TNF-? and MCP-1.
Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.
Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome.
Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease.
Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Relation between serum monocyte chemoattractant protein-1 and coronary collateral development.
Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression.
Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography.
Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction.
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population.
The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts.
The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease.
Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1.
[Expression of monocyte chemotactic protein-1 and its receptor in sudden coronary death].
[Monocyte chemotactic protein-1 expression in coronary atherosclerosis plaque of sudden coronary death patients]
Coronary Disease
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.
Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects.
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Coronary Occlusion
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Costello Syndrome
Tropoelastin regulates chemokine expression in fibroblasts in Costello syndrome.
COVID-19
Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
Changes of serum IL-10, IL-1?, IL-6, MCP-1, TNF-?, IP-10 and IL-4 in COVID-19 patients.
COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
COVID-19: Is there a role for immunonutrition in obese patient?
Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
MCP-1: Function, regulation, and involvement in disease.
Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19.
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
The understanding of the immunopathology in COVID-19 infection.
Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.
Crohn Disease
Chemokines in the inflammatory bowel diseases.
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease.
SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
Cryptococcosis
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
Cryptogenic Organizing Pneumonia
Cytokine profile of broncho-alveolar lavage in BOOP and UIP.
Cystic Fibrosis
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system.
Effects of treatment in the levels of circulating cytokines and growth factors in cystic fibrosis and dialyzed patients by multi-analytical determination with a biochip array platform.
Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays.
Cysts
Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Cytokine and chemokine levels in radicular and residual cyst fluids.
Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Early inflammatory response in epithelial ovarian tumor cyst fluids.
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial.
Expression of adhesion molecules, chemokines and matrix metallo- proteinases (MMPs) in viable and degenerating stage of Taenia solium metacestode in swine neurocysticercosis.
Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis.
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Cytomegalovirus Infections
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
Delirium
Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.
Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte.
Elevated Monocyte Chemoattractant Protein-1 as the Independent Risk Factor of Delirium after Cardiac Surgery. A Prospective Cohort Study.
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients.
Dementia
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.
Biomarkers of HIV-1 CNS infection and injury.
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Glial activation and inflammation along the Alzheimer's disease continuum.
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia.
MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies.
[Chemokines as mediators for intercellular communication in the brain]
Demyelinating Diseases
Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b/s mice.
Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cells.
Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease.
Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.
MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve.
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Dengue
Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.
Cytokine Signature Associated with Disease Severity in Dengue.
MCP-1 and MIP-1alpha expression in a model resembling early immune response to dengue.
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells.
Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Dermatitis
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Glucocorticoid insensitivity by staphylococcal enterotoxin B in keratinocytes of allergic dermatitis is associated with impaired nuclear translocation of the Glucocorticoid Receptor ?.
Inhibitory Effect of Metalloproteinase Inhibitors on Skin Cell Inflammation Induced by Jellyfish Nemopilema nomurai Nematocyst Venom.
Tumor necrosis factor-?, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats.
Dermatitis, Allergic Contact
MCP-1 produced by keratinocytes is associated with leucocyte recruitment during elicitation of nickel-induced occupational allergic contact dermatitis.
Dermatitis, Atopic
Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.
Dermatitis, Contact
Anti-inflammatory Effects of Brassica oleracea Var. capitata L. (Cabbage) Methanol Extract in Mice with Contact Dermatitis.
Chemokine expression in trinitrochlorobenzene-mediated contact hypersensitivity.
Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.
Enhanced contact hypersensitivity in human monocyte chemoattractant protein-1 transgenic mouse.
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.
MCP-1 Priming Enhanced the Therapeutic Effects of Human Mesenchymal Stromal Cells on Contact Hypersensitivity Mice by Activating the COX2-PGE2/STAT3 Pathway.
[Analysis of contact hypersensitivity response in human monocyte chemoattractant protein (MCP)-1 transgenic mice]
Dermatomyositis
Differential expression of chemokines in inflammatory myopathies.
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction.
Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage.
Diabetes Complications
Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis.
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Diabetes Mellitus
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets.
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Association of MCP-1 rs1024611 polymorphism with diabetic foot ulcers.
Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis.
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism.
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
D-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs.
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.
Effect of retinoic acid in experimental diabetic nephropathy.
Enhancement of lens extraction-induced MCP-1 upregulation and microglia response in long-term diabetes via c-jun, stat1 and ERK.
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg.
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
Glucocorticoids use in kidney transplant setting.
Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus.
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes.
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Diabetes Mellitus, Experimental
Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus.
Diabetes Mellitus, Type 1
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets.
Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion.
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes.
Gene expression analysis of human islets in a subject at onset of type 1 diabetes.
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.
Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes.
Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1? in Patients With Type 1 Diabetes.
Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes.
Diabetes Mellitus, Type 2
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis.
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism.
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.
Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis.
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1?, and TNF? levels in type 2 diabetes and insulin resistance.
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.
Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes.
Effects of Liraglutide Combined with Insulin on Oxidative Stress and Serum MCP-1 and NF-kB Levels in Type 2 Diabetes.
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.
Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes.
Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg.
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro.
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes.
Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
Methylation Status of CpG Sites in the MCP-1 Promoter is Correlated to Serum MCP-1 in type 2 Diabetes.
Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population.
Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy.
Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Podocyte as a potential target of inflammation: role of pioglitazone hydrochloride in patients with type 2 diabetes.
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
The DNA methylation of TNF-aplha, MCP-1, and adiponectin in visceral adipose tissue is related to type 2 diabetes in Xinjiang Uygur population.
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Diabetes, Gestational
Circulating levels of MCP-1 are increased in women with gestational diabetes.
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Diabetic Angiopathies
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
Diabetic Foot
Association of MCP-1 rs1024611 polymorphism with diabetic foot ulcers.
Correlation between IL-7 and MCP-1 in diabetic chronic non healing ulcer patients at higher risk of coronary artery disease.
Silencing TNF? with lipidoid nanoparticles downregulates both TNF? and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer.
Diabetic Nephropathies
A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells.
A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?
ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Colchicine Attenuates Inflammatory Cells Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Detection of urinary MCP-1 in patients with diabetic nephropathy.
Effect of retinoic acid in experimental diabetic nephropathy.
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Effects of mycophenolate mofetil on the expression of monocyte chemoattractant protein-1 and fibronectin in high glucose cultured human mesangial cells.
Effects of Tumor Necrosis Factor-? on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy.
Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy.
Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse.
Full composition granules of Huanglian (Rhizoma Coptidis) decrease the serum monocyte chemotactic protein-1 and connective tissue growth factor levels and inhibit kidney nuclear factor-?B expression in rats with high-fat diet-induced diabete.
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy.
Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-?B Signaling Pathway.
Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats.
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
Metformin inhibits TGF-beta 1-induced MCP-1 expression through BAMBI-mediated suppression of MEK/ERK1/2 signaling.
Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy.
miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression.
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.
Monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-{beta}, increases podocyte motility and albumin permeability.
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
Nifedipine, a calcium-channel blocker, inhibits advanced glycation end-product-induced expression of monocyte chemoattractant protein-1 in human cultured mesangial cells.
Nuclear NF-?B p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy.
Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.
Rosiglitazone ameliorates diabetic nephropathy by inhibiting reactive oxygen species and its downstream-signaling pathways.
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
Suppressor of Cytokine Signaling-1 Ameliorates Expression of MCP-1 in Diabetic Nephropathy.
Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease.
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.
TRB3: an oxidant stress-induced pseudokinase with a potential to negatively modulate MCP-1 cytokine in diabetic nephropathy.
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
[Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy]
[Randomized and controlled study on needling method of harmonizing spleen-stomach for early intervention of diabetic nephropathies and the mechanism of protecting kidney]
Diabetic Neuropathies
Biomarkers in diabetic neuropathy.
Diabetic Retinopathy
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
ATF4 is a novel regulator of MCP-1 in microvascular endothelial cells.
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitus.
Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy.
Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Elevated serum monocyte chemoattractant protein-1 levels and its genetic polymorphism is associated with diabetic retinopathy in Chinese patients with Type 2 diabetes.
Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism.
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.
Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.
Serum inflammatory markers in diabetic retinopathy.
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro.
Dry Eye Syndromes
Corneal regeneration by conditioned medium of human uterine cervical stem cells is mediated by TIMP-1 and TIMP-2.
Dyslipidemias
Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia.
Aging and Hyperglycemia Intensify Dyslipidemia-Induced Oxidative Stress and Inflammation in Rats: Assessment of Restorative Potentials of ALA and EPA + DHA.
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study.
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Obese Mexican American children have elevated MCP-1, TNF-?, monocyte concentration, and dyslipidemia.
Echinococcosis
Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region.
MCP-1 and MIP-2 levels during Echinococcus granulosus infections in mice.
Eczema
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
Embolic Stroke
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Encephalitis
A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease.
Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis.
Biomarkers of HIV-1 CNS infection and injury.
Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis.
Cerebrospinal fluid markers that predict SIV CNS disease.
Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation.
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
Expression Kinetics of RANTES and MCP-1 in the Brain of Deer Mice (Peromyscus maniculatus) Infected with Vesicular Stomatitis New Jersey Virus.
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
MCP-1 induces migration of adult neural stem cells.
MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
[Tick-borne encephalitis virus (TBEV) enhances the expression of MCP-1, CD68 and NF-?B in infected mouse brain tissue].
Encephalitis, Herpes Simplex
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Encephalitis, Japanese
Association of ICAM-1 (K469E) and MCP-1-2518 A?>?G polymorphism with risk of Japanese encephalitis in North Indian population.
Encephalitis, Tick-Borne
[Evaluation of soluble platelet cell adhesion molecule sPECAM-1 and chemokine MCP-1 (CCL2) concentration in CSF of patients with tick-borne encephalitis]
Encephalomyelitis
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Encephalomyelitis, Autoimmune, Experimental
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis.
Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats.
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Endocarditis
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Endometrial Neoplasms
Expression of monocyte chemotactic protein-1 in human endometrial cancer cells and the effect of treatment with tamoxifen or buserelin.
Endometriosis
Addition of MCP-1 and MIP-3? to the IL-8 appraisal in peritoneal fluid enhances the probability of identifying women with endometriosis.
Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex® platform.
Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis.
Correlation between decreased type-II interleukin-1 receptor and increased monocyte chemotactic protein-1 expression in the endometrium of women with endometriosis.
Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis.
Differential flow cytometric detection of intracellular cytokines in peripheral and peritoneal mononuclear cells of women with endometriosis.
Effect of IL-1 beta and TNF-alpha on the expression of monocyte chemotactic protein-1 in endometriotic cells.
Effect of monocyte chemoattractant protein-1 and estradiol on the secretion of vascular endothelial growth factor in endometrial stromal cells in vitro.
Effect of oxytocin treatment on explant size, plasma and peritoneal levels of MCP-1, VEGF, TNF-? and histopathological parameters in a rat endometriosis model.
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial.
Effects of 17?-estradiol on the release of monocyte chemotactic protein-1 and MAPK activity in monocytes stimulated with peritoneal fluid from endometriosis patients.
Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis.
Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis.
Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
Endometrial stromal cells treated by tumor necrosis factor-? stimulate macrophages polarized toward M2 via interleukin-6 and monocyte chemoattractant protein-1.
Endometriosis-associated changes in serum levels of interferons and chemokines.
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis.
Expression of monocyte chemoattractant protein-1 in peritoneal endometriotic cells.
Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis.
Focal Adhesion Kinase-Mediated Sequences, Including Cell Adhesion, Inflammatory Response, and Fibrosis, as a Therapeutic Target in Endometriosis.
Functional changes of immune cells: signal of immune tolerance of the ectopic lesions in endometriosis?
Higher activity by opaque endometriotic lesions than nonopaque lesions.
Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis.
Induction of monocyte chemotactic protein-1 in peritoneal mesothelial and endometrial cells by oxidized low-density lipoprotein and peritoneal fluid from women with endometriosis.
Is Endometriosis Associated with Systemic Subclinical Inflammation?
Macrophages, oxidation, and endometriosis.
Peritoneal fluid concentrations of ?-chemokines in endometriosis.
Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility.
Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization.
Regulation of monocyte chemotactic protein-1 expression in human endometrial endothelial cells by sex steroids: a potential mechanism for leukocyte recruitment in endometriosis.
Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis. Le groupe d'investigation en gynécologie.
Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.
Soluble interleukin-1 receptor type II blocks monocyte chemotactic protein-1 secretion by U937 cells in response to peripheral blood serum of women with endometriosis.
Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis.
The G(-2518)A polymorphism of monocyte chemotactic protein-1 (MCP-1) and its serum and peritoneal fluid levels in Korean women with endometriosis.
The peritoneal environment in endometriosis.
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation.
TSLP induced by estrogen stimulates secretion of MCP-1 and IL-8 and growth of human endometrial stromal cells through JNK and NF-?B signal pathways.
Uterine chemokines in reproductive physiology and pathology.
[Determination of monocyte chemotactic protein-1 in cultured endometriotic cells]
[Expression of monocyte chemotacticp protein-1 in the eutopic endometrium of women with endometriosis]
Endophthalmitis
Elevated cytokine levels in vitreous as biomarkers of disease severity in infectious endophthalmitis.
Intraocular Cytokine Levels in Post-Cataract Endophthalmitis and their Association with Visual Outcome.
Endotoxemia
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Acute alcohol intoxication and gadolinium chloride attenuate endotoxin-induced release of CC chemokines in the rat.
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression.
Canscora lucidissima, a Chinese folk medicine, exerts anti-inflammatory activities by inhibiting the phosphorylation of ERK1/2 in LPS-activated macrophages.
Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees.
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia.
Heat stress decreases pulmonary MCP-1 production in endotoxemia.
Impact of insulin on the intestinal microcirculation in a model of sepsis-related hyperglycemia.
MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat.
MCP-1 gene activation marks acute kidney injury.
MCP-1 protects mice in lethal endotoxemia.
MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.
Role of MCP-1 in endotoxemia and sepsis.
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.
Enteritis
Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis.
Eosinophilia
Factors contributing to nasal allergic late phase eosinophilia.
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma.
Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks.
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.
[Clinical Symptoms and Mediators in the Allergic Early and Late Phase Reaction.]
Epilepsy
Cellular injury and neuroinflammation in children with chronic intractable epilepsy.
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Epiretinal Membrane
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Epstein-Barr Virus Infections
Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.
Erythema
A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats.
Escherichia coli Infections
Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli.
Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection.
Esophageal Achalasia
Multiplex immunoassays reveal increased serum cytokines and chemokines associated with the subtypes of achalasia.
Esophageal Squamous Cell Carcinoma
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Esophagitis
Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?
Esophagitis, Peptic
Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?
Essential Hypertension
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension.
Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.
Familial Primary Pulmonary Hypertension
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Farber Lipogranulomatosis
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
Fatty Liver
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Chlorella Protein Hydrolysate Attenuates Glucose Metabolic Disorder and Fatty Liver in High-fat Diet-induced Obese Mice.
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet.
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Oxysterols in the orchestra of liver cell metabolism.
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
[Effects and mechanisms of punicosides on acute alcoholic liver damage in mice].
Fatty Liver, Alcoholic
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Fibromyalgia
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.
MCP-1 and IL-8 as Pain Biomarkers in Fibromyalgia: A Pilot Study.
Foot Ulcer
Association of MCP-1 rs1024611 polymorphism with diabetic foot ulcers.
Silencing TNF? with lipidoid nanoparticles downregulates both TNF? and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer.
Frontotemporal Lobar Degeneration
MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.
Fuchs' Endothelial Dystrophy
Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet's Stripping Automated Endothelial Keratoplasty.
Gastritis
Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells.
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1? expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice.
Gastroenteritis
Monocyte Chemoattractant Protein (MCP)-1 in Rotavirus-Associated White Matter Injury in Newborns.
Giant Cell Arteritis
MCP-1 gene haplotype association in biopsy proven giant cell arteritis.
Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.
Gingivitis
MIP-1? and MCP-1 as salivary biomarkers in periodontal disease.
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease.
Glaucoma
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Monocyte Chemotactic Protein-1 Level in the Aqueous Humor as a Prognostic Factor for the Outcome of Trabeculectomy.
Tear Cytokine Profile in Medicated Glaucoma Patients Effect of Monocyte Chemoattractant Protein 1 on Early Posttrabeculectomy Outcome.
Glaucoma, Neovascular
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Glioblastoma
A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
CC chemokine receptor-2A is frequently overexpressed in glioblastoma.
Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology.
Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells.
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro.
Interleukin-8 and monocyte chemotactic protein-1 production by a human glioblastoma cell line, T98G in coculture with monocytes: involvement of monocyte-derived interleukin-1alpha.
MCP-1 and MIP-3? Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Role of Cysteine-rich 61 Protein (CCN1) in Macrophage-mediated Oncolytic Herpes Simplex Virus Clearance.
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen.
Glioma
A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.
CC chemokine receptor-2A is frequently overexpressed in glioblastoma.
Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro.
Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma.
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: Involvement of ATP and P2X(7) receptor.
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X? receptor.
Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium.
Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.
Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.
Increased monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha can mediate macrophage infiltration in gliomas.
Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.
Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells.
Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells.
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.
The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme.
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.
Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.
Gliosarcoma
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Glomerulonephritis
A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats.
AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis.
CCAAT/enhancer-binding protein-delta is induced in mesangial area during the early stages of anti-Thy1.1 glomerulonephritis and regulates cell proliferation and inflammatory gene expression in cultured rat mesangial cells.
Cell to cell interaction between mesangial cells and macrophages induces the expression of monocyte chemoattractant protein-1 through nuclear factor-kappaB activation.
Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis.
Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.
Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.
IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells.
In vitro effects of Habu snake venom on cultured mesangial cells.
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice.
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis.
MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis.
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis.
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1.
Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells.
Production of monocyte chemoattractant protein-1 by cultured glomerular epithelial cells: inhibition by dexamethasone.
Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury.
Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
[Expression of MCP-1 in renal tissues of patients with IgA nephropathy]
[Expression of monocyte chemoattractant protein-1 in experimental rat glomerulonephritis is mediated by NF-kappaB/IkappaB signal pathway]
Glomerulonephritis, IGA
Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
Enhanced expression of C chemokine lymphotactin in IgA nephropathy.
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy risk.
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis.
No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy.
Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy.
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor ?1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
[Effects of Artesunate on MCP-1 and MCP-1 mRNA expression of renal tissue in the rat IgA nephropathy model]
[Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy]
[Expression of MCP-1 in renal tissues of patients with IgA nephropathy]
Glomerulonephritis, Membranous
Effects of sodium houttuyfonate on expression of NF-kappaB and MCP-1 in membranous glomerulonephritis.
Fn14 in podocytes and proteinuric kidney disease.
Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis.
Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Glomerulosclerosis, Focal Segmental
Fn14 in podocytes and proteinuric kidney disease.
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor ?1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Glucose Intolerance
Adverse Effects of Methylglyoxal on Transcriptome and Metabolic Changes in Visceral Adipose Tissue in a Prediabetic Rat Model.
Early Onset Inflammation in Pre-Insulin-Resistant Diet-Induced Obese Rats Does Not Affect the Vasoreactivity of Isolated Small Mesenteric Arteries.
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Glucocorticoids use in kidney transplant setting.
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Role of Vascular Oxidative Stress in Obesity and Metabolic Syndrome.
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
The Effects of High-Protein Diet and Resistance Training on Glucose Control and Inflammatory Profile of Visceral Adipose Tissue in Rats.
The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity.
Gout
Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL/6 mice.
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients.
Gram-Positive Bacterial Infections
Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.
Enhanced wound-healing performance of a phyto-polysaccharide-enriched dressing - a preclinical small and large animal study.
Granuloma
A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-?B signaling in mice.
Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo.
Augmentation of monocyte chemotactic protein-1 and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo.
Chemokine responses in schistosomal antigen-elicited granuloma formation.
Chemokines in inflammatory states.
Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Detection of Experimentally Induced Pulmonary Granuloma Inflammation in Monocyte Chemoattractant Protein-1 Reporter Mice.
Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.
Expression of chemokines and gelatinase B in sympathetic ophthalmia.
Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits.
Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
Hesperidin methyl chalcone alleviates spinal tuberculosis in New Zealand white rabbits by suppressing immune responses.
Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis.
Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model.
Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells.
MCP-1 and RANTES are mediators of acute and chronic inflammation.
Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.
Monocyte chemotactic protein-1 gene expression and translation in formed granulomatous calcified tissue in vivo.
Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks.
Neutrophils and reactive oxygen intermediates mediate glucan-induced pulmonary granuloma formation through the local induction of monocyte chemoattractant protein-1.
Nitric oxide interaction with IL-10, MIP-1alpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis.
Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis.
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.
Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1.
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Role of monocyte chemoattractant protein-1 in Propionibacterium acnes-induced pulmonary granulomatosis.
Graves Ophthalmopathy
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
Hamman-Rich Syndrome
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Hand, Foot and Mouth Disease
Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.
Head and Neck Neoplasms
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Hearing Loss
Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.
Heart Arrest
Minimal changes of TNF-alpha and MCP-1 expression in blood serum of rats subjected to experimental cardiac arrest.
Heart Diseases
Anti-chemokine therapy for inflammatory diseases.
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: a family-based investigation.
MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Heart Failure
Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling.
Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells.
Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.
Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-? Signaling.
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Dobutamine inhibits monocyte chemoattractant protein-1 production and chemotaxis in human monocytes.
Elevated circulating levels of C-C chemokines in patients with congestive heart failure.
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
Galectin-3 Is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes.
Induction of early biomarkers in a thrombus-induced sheep model of ischemic heart failure.
Macrophage-modulating cytokines predict adverse outcome in heart failure.
MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.
Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure.
Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy.
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure.
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.
Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.
The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Heart Rupture
Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP.
Hemangioendothelioma
Nox-4 Dependent Nuclear H2O2 Drives DNA Oxidation Resulting in 8-OHdG as Urinary Biomarker and Hemangioendothelioma Formation.
Hemangioma
Berry anthocyanins as novel antioxidants in human health and disease prevention.
Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells.
Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations.
Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.
Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Hemarthrosis
Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.
Hematuria
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
Hemochromatosis
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Hemophilia A
IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis.
Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.
Hemorrhagic Fever, Crimean
Association of MCP-1 promotor polymorphism with disease severity of Crimean-Congo hemorrhagic fever.
Hemorrhagic Stroke
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Henipavirus Infections
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatic Encephalopathy
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Hepatitis
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Expression of IFN-inducible protein-10 in chronic hepatitis.
Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10.
Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration.
Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
Hepatitis B
RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Hepatitis B, Chronic
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.
Relationship among MIF, MCP-1, viral loads, and HBs Ag levels in chronic hepatitis B patients.
[Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].
Hepatitis C
Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES.
Expression of IFN-inducible protein-10 in chronic hepatitis.
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
[TLR9 expression and its relationship with MCP-1 and TNF-? in HCV-stimulated BV2 cells].
Hepatitis C, Chronic
Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.
Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C.
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
[Chronic HCV-infection and expression of mRNA of CC-chemokines and their receptors]
Hepatitis, Alcoholic
Increased monocyte MCP-1 production in acute alcoholic hepatitis.
Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Hepatitis, Chronic
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Expression of IFN-inducible protein-10 in chronic hepatitis.
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
Hepatomegaly
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Hepatopulmonary Syndrome
Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome.
Herpes Simplex
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.
HIV Infections
Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.
Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.
Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
Potential gingival crevicular fluid and serum biomarkers by stage of HIV infection.
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy.
Hodgkin Disease
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Homozygous Familial Hypercholesterolemia
Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.
HTLV-I Infections
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Huntington Disease
Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction.
Hydronephrosis
Diagnostic value of urinary RBP, ALB and AQP2 in neonatal hydronephrosis and the relationship with expression of MCP-1 in the prenatal maternal peripheral blood.
Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis.
Urinary biomarkers in hydronephrosis.
Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
Urinary IP-10, MCP-1, NGAL, Cystatin-C, and KIM-1 Levels in Prenatally Diagnosed Unilateral Hydronephrosis: The Search for an Ideal Biomarker.
Hyperalgesia
ATP-sensitive potassium channels alleviate postoperative pain through JNK-dependent MCP-1 expression in spinal cord.
Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican.
Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain.
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
miR-125a-5p in astrocytes attenuates peripheral neuropathy in type 2 diabetic mice through targeting TRAF6.
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.
Monocyte chemoattractant protein-1-induced excitation and sensitization to mechanical stimulation of mechanosensitive C-fiber afferents in rat skin.
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.
PI3K/Akt Signaling Pathway may be involved in MCP-1-induced P2X4R Expression in cultured microglia and Cancer-induced Bone Pain Rats.
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Spinal injection of TNF-?-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.
Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis.
Hyperandrogenism
Does oral contraceptive pill increase plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-? levels in women with Polycystic Ovary Syndrome (PCOS): A pilot study.
Hypercholesterolemia
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
Chronic exercise reduces adhesion molecules/iNOS expression and partially reverses vascular responsiveness in hypercholesterolemic rabbit aortae.
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats.
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Probucol plus cilostazol attenuate hypercholesterolemia?induced exacerbationin ischemic brain injury via anti-inflammatory effects.
[Increase of choroidal and scleral MCP-1 expression in hypercholesterolemia experimental model].
Hyperemia
Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis.
Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover study.
Hypereosinophilic Syndrome
The roles of MCP-1 and protein kinase Cdelta activation in human eosinophilic leukemia EoL-1 cells.
Hyperglycemia
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes.
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats.
Effect of short-term hyperglycemia on adipose tissue fluxes of selected cytokines in vivo during multiple phases of diet-induced weight loss in obese women.
Evidence of proatherogenic inflammation in polycystic ovary syndrome.
Glycemic memory associated epigenetic changes.
Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells.
Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress.
Hyperglycemia induces NF-?B activation and MCP-1 expression via downregulating GLP-1R expression in rat mesangial cells: inhibition by metformin.
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Monocyte Chemoattractant Protein 1 Is Correlated With Glycemic Control and Peripheral Arterial Disease in Type 2 Diabetic Patients With Metabolic Syndrome.
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice.
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.
Hyperhomocysteinemia
Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems.
Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation.
Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation.
Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-?B/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.
Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules.
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages.
[Folate reduces monocyte chemoattractant protein-1 expression in rats with hyperhomocysteinemia]
Hyperinsulinism
Effect of Ursolic Acid on Insulin Resistance and Hyperinsulinemia in Rats with Diet-Induced Obesity: Role of Adipokines Expression.
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Monocyte chemoattractant protein 1 in obesity and insulin resistance.
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
Hyperlipidemias
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.
Evidence on n-3 Fatty Acids and Oleic Acid Role in Retinal Inflammation and Microvascular Integrity: Insight from a Hyperlipidemic Rat Model.
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
Possible involvement of PI3K-dependent pathways in the increased VEGF120 release from osteoblastic cells preloaded with palmitate in vitro.
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
The expression of monocyte chemoattractant protein-1 and C-C chemokine receptor 2 in post-kidney transplant patients and the influence of simvastatin treatment.
[Effect of electroacupuncture stimulation of "Fenglong" (ST 40) on expression of inflammatory cytokines of celiac macrophages in hyperlipidemia rats].
Hyperlipoproteinemias
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb.
Hyperoxaluria
Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice.
Experimentally induced hyperoxaluria in MCP-1 null mice.
Hypersensitivity
Anti-Inflammatory and Immunomodulatory Effects of Bortezomib in Various in vivo Models.
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments.
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects.
Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy induced peripheral neuropathy.
Effect of roasted peanut allergen Ara h 3 protein on the sensitization of Caco-2 cells.
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1.
Ligustilide attenuates inflammatory pain via inhibition of NF?B-mediated chemokines production in spinal astrocytes.
Monocyte chemoattractant peptide-1 expression during cutaneous allergic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response.
Monocyte Chemoattractant Protein 1 Expression in Synovial Fluid of Patients With Total Hip Arthroplasty.
Role of quercetin (a natural herbal compound) in allergy and inflammation.
Transgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Hypersensitivity, Delayed
Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.
Hypersensitivity, Immediate
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
Hypertension
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Adrenomedullin inhibits pressure-induced mesangial MCP-1 expression through activation of protein kinase A.
Angiotensin ? Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.
Anti-inflammatory Effects of ?-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II-Dependent Hypertension.
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients.
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
Co-Inheritance of Autosomal Dominant Polycystic Kidney Disease and Naevoid Basal Cell Carcinoma Syndrome: Effects on Renal Progression.
Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney.
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects.
MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension.
Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone.
Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats.
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Nephrin and endothelial injury.
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Peroxisome Proliferator Activated Receptor-? Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase.
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Role of aortic stiffness and inflammation in the etiology of young-onset hypertension
Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor ? B Protein in Spontaneously Hypertensive Rats.
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
Sex-, Age-, and Metabolic Disorder-Dependent Distributions of Selected Inflammatory Biomarkers among Community-Dwelling Adults.
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.
The role of chemokines in hypertension.
Thiazide diuretics, endothelial function, and vascular oxidative stress.
Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms.
Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
[Expression of monocyte chemoattractant protein-1 in aorta of early hypertensive rats]
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
[The best of hypertension 2005]
[The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection]
Hypertension, Portal
Does hepatic vagus nerve modulate the progression of biliary fibrosis in rats?
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
The role of monocyte chemoattractant protein-1 in biliary atresia.
Hypertension, Pregnancy-Induced
Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort.
Hypertension, Pulmonary
Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1.
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension.
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Hyperthyroidism
Increased susceptibility of hyperthyroid rats to ozone: early events and mechanisms.
Influence of hyperthyroidism on rat lung cytokine production and nuclear factor-kappaB activation following ozone exposure.
Hypertriglyceridemia
Association between serum cytokine concentrations and the presence of hypertriglyceridemia.
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Hypertrophy, Left Ventricular
MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Thiazide diuretics, endothelial function, and vascular oxidative stress.
Hypertrophy, Right Ventricular
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats.
Hypotension
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
Hypothyroidism
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.
Hypoxia-Ischemia, Brain
Blood Biomarkers and 6- to 7-Year Childhood Outcomes Following Neonatal Encephalopathy.
Idiopathic Interstitial Pneumonias
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Idiopathic Pulmonary Fibrosis
Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
[Serum biomarkers in idiopathic pulmonary fibrosis.]
IgA Vasculitis
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Ileitis
Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice.
Ileus
MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat.
Immune Complex Diseases
Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Immune System Diseases
[Effect of intravenous lornoxicam at different doses on the immune function in patients undergoing total abdominal hysterectomy.]
Immunoglobulin G4-Related Disease
Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Infarction, Middle Cerebral Artery
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment.
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.
Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats.
MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke.
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.
Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression.
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
Infections
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.
A MyD88-dependent IFN?R-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge.
A novel CCR-2/TLR-2 triggered signaling in murine peritoneal macrophages intensifies bacterial (Staphylococcus aureus) killing by reactive oxygen species through TNF-R1.
A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease.
Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.
Activating transcription factor 4 (ATF4) is upregulated by human herpesvirus 8 infection, increases virus replication and promotes proangiogenic properties.
Activation of glial cells by human coronavirus OC43 infection.
Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm.
Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice.
Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-? and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors.
Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells.
Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.
Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo.
Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation.
Adrenal Steroids Modulate Fibroblast-Like Synoviocytes Response During B. abortus Infection.
Aging Reduces the Expression of Lung CINC and MCP-1 mRNA in a P. aeruginosa Rat Model of Infection.
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections.
An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.
An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions.
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection.
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.
Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion.
Arcobacter butzleri Induce Colonic, Extra-Intestinal and Systemic Inflammatory Responses in Gnotobiotic IL-10 Deficient Mice in a Strain-Dependent Manner.
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.
Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function.
Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.
Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.
Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.
Breast Milk from Tanzanian Women Has Divergent Effects on Cell-Free and Cell-Associated HIV-1 Infection In Vitro.
Brucella abortus Proliferates in Decidualized and Non-Decidualized Human Endometrial Cells Inducing a Proinflammatory Response.
Brucella invasion of human intestinal epithelial cells elicits a weak proinflammatory response but a significant CCL20 secretion.
CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
CCR5, MCP-1 and VDR Gene Polymorphisms Are Associated with the Susceptibility to HBV Infection.
Central Nervous System Inflammation and Infection During Early, Non-Accelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
Cerebrospinal fluid markers that predict SIV CNS disease.
Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells.
Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection.
Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002.
Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.
Chemokine and chemokine receptor dynamics during genital chlamydial infection.
Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection.
Chemokine patterns in children with acute bacterial infections.
Chemokine secretion of human cells in response to Toxoplasma gondii infection.
Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus.
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.
Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production.
Chronic Exercise Reduces Illness Severity, Decreases Viral Load, and Results in Greater Anti-Inflammatory Effects than Acute Exercise during Influenza Infection.
Circulating cytokine portraits can differentiate between allograft rejection and pulmonary infection in cardiac transplant rats.
Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resection.
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1.
Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models.
Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children.
Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.
Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.
Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.
Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment.
Cytokine profile and cytoskeletal changes after herpes simplex virus type 1 infection in human trabecular meshwork cells.
Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus-infected human foetal lung fibroblasts.
Cytokines in human milk.
Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome.
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
Data showing differential expression of Monocyte chemoattractant protein-1 in response to symptomatic and asymptomatic T. vaginalis infection.
Defense against influenza A virus infection: essential role of the chemokine system.
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
Detection of serum MCP-1 and TGF-?1 in polymyositis/dermatomyositis patients and its significance.
Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Differences in pig respiratory tract and peripheral blood immune responses to Actinobacillus pleuropneumoniae.
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus.
Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections.
Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.
Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.
Differential regulation of chemokine secretion in tuberculous and staphylococcal osteomyelitis.
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery.
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Dual-Specificity Phosphatase 12 Targets p38 MAP Kinase to Regulate Macrophage Response to Intracellular Bacterial Infection.
Dynamics of transcription of immunomodulatory genes in endothelial cells infected with different coccidian parasites.
Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.
Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthetase and selected inflammatory cytokines in a rat model of acute otitis media.
Effect of Bisphenol A on non-specific immunodefenses against non-pathogenic Escherichia coli.
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Effect of fetal calf serum on cytokine release by bone marrow-derived macrophages during infection with intracellular bacteria.
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures.
Exposure to urban air particulates alters the macrophage-mediated inflammatory response to respiratory viral infection.
Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-kappaB.
Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae.
Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection.
Gastric lesions and immune responses caused by long-term infection with Helicobacter heilmannii in C57BL/6 mice.
Glial Cell-Elicited Activation of Brain Microvasculature in Response to Brucella abortus Infection Requires ASC Inflammasome-Dependent IL-1? Production.
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
GS-9620 inhibits enterovirus 71 replication mainly through the NF-?B and PI3K-AKT signaling pathways.
Heme Oxygenase-1 and Carbon Monoxide Promote Burkholderia pseudomallei Infection.
HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines.
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).
Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene.
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.
Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes.
Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway.
Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.
Human intestinal epithelial cell cytokine mRNA responses mediated by NF-kappaB are modulated by the motility and adhesion process of Vibrio cholerae.
Human lung innate immune cytokine response to adenovirus type 7.
Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan.
Identification of defective early immune responses to Burkholderia pseudomallei infection in a diet-induced murine model of type 2 diabetes.
Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia.
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model.
Impaired cytokine expression, neutrophil infiltration, and bacterial clearance in response to urinary tract infection in diabetic mice.
Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice.
In situ cytokines (IL-4, IL-10, IL-12, IFN-?) and chemokines (MCP-1, MIP-1?) gene expression in human Leishmania (Leishmania) Mexicana infection.
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis.
Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.
Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB.
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli.
Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression.
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro.
Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis.
Infection of human primary hepatocytes with dengue virus serotype 2.
Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice.
Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.
Infection with Leishmania major induces a cellular stress response in macrophages.
Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans.
Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.
Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.
Inhibitory effect of polysaccharide of Sargassum weizhouense on PCV2 induced inflammation in mice by suppressing histone acetylation.
Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection.
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.
JNK regulates MCP-1 expression in adenovirus type 19-infected human corneal fibroblasts.
Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells.
Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis.
Legionella pneumophila suppresses interleukin-12 production by macrophages.
Legionella pneumophila Type II Secretion Dampens the Cytokine Response of Infected Macrophages and Epithelia.
Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
Lipoteichoic acid of Enterococcus faecalis induces the expression of chemokines via TLR2 and PAFR signaling pathways.
Local production of chemokines during experimental vaginal candidiasis.
Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections.
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.
Macrophages and hepatocytic cells as chemokine producers in murine listeriosis.
Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection.
Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
Mayaro Virus Replication Restriction and Induction of Muscular Inflammation in Mice Are Dependent on Age, Type-I Interferon Response, and Adaptive Immunity.
MCP-1 and MIP-2 levels during Echinococcus granulosus infections in mice.
MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis.
MCP-1: chemoattractant with a role beyond immunity: a review.
Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells.
Mechanisms of Porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells.
Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.
Melatonin and Leishmania amazonensis Infection Altered miR-294, miR-30e, and miR-302d Impacting on Tnf, Mcp-1, and Nos2 Expression.
Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
Modulatory effect of HHV-6 on MCP-1 production by human monocytes.
Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation.
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines.
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.
Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response.
mRNA expression of cytokines and chemokines in the normal gastric surface mucous epithelial cell line GSM06 during bacterial infection with Helicobacter felis.
Mumps virus induces innate immune responses in mouse ovarian granulosa cells through the activation of Toll-like receptor 2 and retinoic acid-inducible gene I.
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection.
Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway.
Negative regulation of lung inflammation and immunopathology by TNF-? during acute influenza infection.
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model.
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Noradrenergic Neurons Regulate Monocyte Trafficking and Mortality during Gram-Negative Peritonitis in Mice.
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections.
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response.
Pathophysiologic response to severe burn injury.
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Plasmodium genetic loci linked to host cytokine and chemokine responses.
Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes.
Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice.
Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction.
Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines.
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis.
Proinflammatory response of human endothelial cells to Brucella infection.
Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.
Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge.
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.
RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.
Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis.
Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.
Respiratory echovirus 30 and coxsackievirus B5 can induce production of RANTES, MCP-1 and IL-8 by human bronchial epithelial cells.
Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.
Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness.
Respiratory Syncytial Virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs.
Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs.
Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes.
Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain Differentially Regulate Endothelial Cell Responses.
Rickettsia rickettsii infection of human macrovascular and microvascular endothelial cells reveals activation of both common and cell type-specific host response mechanisms.
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.
Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.
Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-alpha, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes.
Roles Played by Toll-like Receptor-9 in Corneal Endothelial Cells after Herpes Simplex Virus Type 1 Infection.
Rupintrivir reduces RV-induced TH-2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo.
SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways.
Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract.
Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection.
Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence.
Serum Monocyte Chemoattractant Protein-1 Predicts Liver Inflammation of Patients with Chronic Hepatitis B.
Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein-1 expression by endothelial cells.
Signaling lymphocyte-activation molecule SLAMF1 augments mycobacteria BCG-induced inflammatory response and facilitates bacterial clearance.
SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-?B pathway.
Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.
Staphylococcus aureus-mediated blood-brain barrier injury: An in vitro human brain microvascular endothelial cell model.
Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses.
Structural analysis of human CCR2b and primate CCR2b by molecular modeling and molecular dynamics simulation.
Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus.
Survey of small intestinal and systemic immune responses following murine Arcobacter butzleri infection.
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells.
The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs.
The feedback loop of "EMMPRIN/NF-?B" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- ? B Pathway in Mice.
The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage.
The Role of Alveolar Epithelial Cells in Initiating and Shaping Pulmonary Immune Responses: Communication between Innate and Adaptive Immune Systems.
The role of Ca(2+) mediated signaling pathways on the effect of taurine against Streptococcus uberis infection.
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection.
The Role of Toll-Like Receptor 5 in the Innate Immune Response to Acute P. aeruginosa Pneumonia.
The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus.
The understanding of the immunopathology in COVID-19 infection.
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.
Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.
Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro.
Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.
Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.
Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while echinococcus granulosus is strongly mediated by MCP-1, but not MIP-2.
TRPV1 and the MCP-1/CCR2 Axis Modulate Post-UTI Chronic Pain.
Trypanosoma cruzi Infection Induces Cellular Stress Response and Senescence-Like Phenotype in Murine Fibroblasts.
Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.
Up-regulation of pro-inflammatory factors by HP-PRRSV infection in microglia: Implications for HP-PRRSV neuropathogenesis.
Upper Urinary Tract Infections Are Associated with RANTES Promoter Polymorphism.
Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.
Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection.
Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment.
Viral and host correlates of serum resistin in simian AIDS.
Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells.
Virulence of Mycobacterium tuberculosis affects interleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes.
Vitamin A Modifies the Intestinal Chemokine and Cytokine Responses to Norovirus Infection in Mexican Children.
Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Wnt5a is involved in LOX-1 and TLR4 induced host inflammatory response in peri-implantitis.
[Cell immunity response in human pulmonary tuberculosis. Review]
[Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].
[Expression profiles of microRNA in peripheral blood mononuclear cells and immune factors in pregnant women with hepatitis B virus infection].
[Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients]
[Monocyte chemotactic protein-1 gene polymorphism and monocyte chemotactic protein-1 expression in Chongqing Han children with tuberculosis]
[Tick-borne encephalitis virus (TBEV) enhances the expression of MCP-1, CD68 and NF-?B in infected mouse brain tissue].
[TLR9 expression and its relationship with MCP-1 and TNF-? in HCV-stimulated BV2 cells].
Infertility
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization.
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
Inflammatory Bowel Diseases
Association of chemokine and chemokine receptor polymorphisms with activity degree of IBD in Tunisian patients.
Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.
Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa.
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease.
The -2518 A/G MCP-1 polymorphism as a risk factor of inflammatory bowel disease.
The -A2518G Polymorphism in the MCP-1 Gene and Inflammatory Bowel Disease Risk_ A Meta-Analysis.
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
The Role of Inflammatory Cytokines as Intermediates in the Pathway from Increased Adiposity to Disease.
Tissue cytokine and chemokine expression in inflammatory bowel disease.
Influenza, Human
1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice.
Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection.
Antibody and inflammatory response-mediated severity of pandemic 2009 (pH1N1) influenza virus.
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
Defense against influenza A virus infection: essential role of the chemokine system.
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus.
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.
Dual regulatory effect of plant extracts of Forsythia suspense on RANTES and MCP-1 secretion in influenza A virus-infected human bronchial epithelial cells.
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.
GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma.
Inflammatory responses in influenza A virus infection.
Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Lariciresinol-4-O-?-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response.
MCP-1 Antibody Treatment Enhances Damage and Impedes Repair of the Alveolar Epithelium in Influenza Pneumonitis.
Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Negative regulation of lung inflammation and immunopathology by TNF-? during acute influenza infection.
Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine.
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.
Studies on the Bioactive Flavonoids Isolated from Pithecellobium clypearia Benth.
Insulin Resistance
12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice.
A possible association between the -2518 A>G MCP-1 polymorphism and insulin resistance in school children.
Adipocyte death, adipose tissue remodeling, and obesity complications.
An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue.
Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.
Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children.
Chemokine and free fatty acid levels in insulin-resistant state of successful pregnancy: a preliminary observation.
Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women.
Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1?, and TNF? levels in type 2 diabetes and insulin resistance.
Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?
Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle.
Early Regression of Carotid Intima-Media Thickness after Bariatric Surgery and Its Relation to Serum Leptin Reduction.
EET Agonist Rescues the Metabolic Syndrome Phenotype of HO-2 Null Mice.
Effect of a High-fat Diet on 24-Hour Pattern of Circulating Adipocytokines in Rats.
Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
Effect of ARB on expression of CD68 and MCP-1 in adipose tissue of rats on long-term high fat diet.
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.
Expression of chemokine receptors in insulin-resistant human skeletal muscle cells.
Freeze-dried strawberry and blueberry attenuates diet-induced obesity and insulin resistance in rats by inhibiting adipogenesis and lipogenesis.
From excess adiposity to insulin resistance: The role of free fatty acids.
Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr
Growth hormone (GH) differentially regulates NF-kB activity in preadipocytes and macrophages: implications for GH's role in adipose tissue homeostasis in obesity.
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.
High-Fat Diets Containing Different Amounts of n3 and n6 Polyunsaturated Fatty Acids Modulate Inflammatory Cytokine Production in Mice.
Hyperbaric oxygen therapy increases insulin sensitivity in overweight men with and without type 2 diabetes.
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes.
JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.
L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose.
L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats.
Loss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue.
Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis.
Macrophage chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected].
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population.
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism is associated with post-challenge insulin and glucose levels in non-diabetic Japanese subjects.
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
Muscle-specific inflammation induced by MCP-1 overexpression does not affect whole-body insulin sensitivity in mice.
Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort.
Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance.
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
Plasma monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome and associated with adiposity, but unaffected by pioglitazone treatment.
PM2.5 aggravates diabetes via the systemically activated IL-6-mediated STAT3/SOCS3 pathway in rats' liver.
Pro-inflammatory gene expression profile in obese adults with high plasma GIP levels.
Prophylactic role of vitamin K supplementation on vascular inflammation in type 2 diabetes by regulating the NF-?B/Nrf2 pathway via activating Gla proteins.
Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-induced Obese Mice.
Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats.
Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Stress Augments Insulin Resistance and Prothrombotic State: Role of Visceral Adipose-Derived Monocyte Chemoattractant Protein-1.
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice.
The effect of hypolipidemic treatment on monocyte cytokine release in different age groups of patients with type 2 diabetes and atherogenic dyslipidemia.
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance.
Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension.
Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome.
Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome.
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
[The impacts of testosterone on insulin sensitivity and chronic low-grade].
Insulinoma
IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.
The Novel Mechanisms Concerning the Inhibitions of Palmitate-Induced Proinflammatory Factor Releases and Endogenous Cellular Stress with Astaxanthin on MIN6 ?-Cells.
Intermittent Claudication
Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia.
Intervertebral Disc Degeneration
Effects of IL-1?, IL-20, and BMP-2 on Intervertebral Disc Inflammation under Hypoxia.
Extracellular osmolarity regulates matrix homeostasis in the intervertebral disc and articular cartilage: evolving role of TonEBP.
Sirt1 suppresses MCP-1 production during the intervertebral disc degeneration by inactivating AP-1 subunits c-Fos/c-Jun.
Intervertebral Disc Displacement
A potential role of thymic stromal lymphopoietin in the recruitment of macrophages to mouse intervertebral disc cells via monocyte chemotactic protein 1 induction: implications for herniated discs.
Low-intensity pulsed ultrasound stimulation enhances TIMP-1 in nucleus pulposus cells and MCP-1 in macrophages in the rat.
Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation.
Intracranial Aneurysm
Effect of dietary ? carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E(-/-) mice.
Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells.
Expression of NF-?B, MCP-1 and MMP-9 in a Cerebral Aneurysm Rabbit Model.
Ratio of IL-8 in CSF versus Serum Is Elevated in Patients with Unruptured Brain Aneurysm.
Role of inflammatory responses in the pathogenesis of human cerebral aneurysm.
Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms.
Sustained expression of MCP-1 by low wall shear stress loading concomitant with turbulent flow on endothelial cells of intracranial aneurysm.
Sustained expression of MCP-1 induced low wall shear stress loading in conjunction with turbulent flow on endothelial cells of intracranial aneurysm.
The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-?B, MCP-1 and MMP-9.
Iron Deficiencies
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
Iron Overload
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Ischemic Stroke
Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes.
Association of monocyte chemoattractant protein-1 -2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke.
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Coupling of neurogenesis and angiogenesis after ischemic stroke.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Lack of association between MCP-1 -2518A/G polymorphism and ischemic stroke: From a case-control study to an updated meta-analysis.
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities.
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex.
Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: The PRIME Study.
Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.
The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.
Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India.
Joint Diseases
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Keloid
Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids.
[Microvessel counts and the expressions of chemotactic factors in the pathological scar tissues]
Keratitis
Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10.
Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis.
Ketosis
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Kidney Calculi
Calcium oxalate monohydrate crystals stimulate monocyte chemoattractant protein-1 and transforming growth factor ?1 expression in human renal epithelial cells.
Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals.
Urinary extracellular vesicles associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.
Kidney Diseases
Biomarkers of inflammation and repair in kidney disease progression.
Comparison of serum monocide chemoattractant protein levels with immunosuppressive therapy protocols in patients with renal transplantation.
Experimental glomerulosclerosis: Defektheilung of the kidney.
Fn14 in podocytes and proteinuric kidney disease.
Glucocorticoids use in kidney transplant setting.
MCP-1 gene activation marks acute kidney injury.
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease.
Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage.
Kidney Diseases, Cystic
Renal CD14 expression correlates with the progression of cystic kidney disease.
Kidney Failure, Chronic
Association between Monocyte Chemoattractant Protein-1 -2518 (A/G) Single Nucleotide Polymorphism and Chronic Periodontitis in End-stage Renal Disease Patients - A Case-control Study.
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease.
MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease.
Monocyte chemoattractant protein-1 (MCP-1) g.-2518A>G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab.
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on hemodialysis.
RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure.
The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.
Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms.
Latent Infection
Combined Analysis of IFN-?, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Latent Tuberculosis
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Evaluation of the Diagnostic Efficacy of Monocyte Parameters and MCP-1 to Distinguishing Active Tuberculosis from Latent Tuberculosis.
Leg Ulcer
Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice.
Leiomyoma
Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus.
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata.
Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis.
Leishmaniasis
Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages.
Leishmaniasis, Cutaneous
Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.
Leprosy
New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls.
Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage.
Leprosy, Paucibacillary
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Leprosy, Tuberculoid
CXCL10, MCP-1, and other immunologic markers involved in neural leprosy.
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Leptospirosis
Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice.
Importance of KIM-1 and MCP-1 in Determining the Leptospirosis-Associated AKI: A Sri Lankan Study.
Leukemia
9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells.
Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli.
Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target.
Expression of human monocyte chemoattractant protein-1 in the yeast Pichia pastoris.
Immune system modulates the function of adult neural stem cells.
Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-kappaB-independent mechanism.
MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid.
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716.
The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis.
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.
Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-? pathway.
[Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells]
Leukemia, Feline
Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Leukemia, Monocytic, Acute
Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-? pathway.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells]
Leukemia, Myeloid, Acute
LINC01255 combined with BMI1 to regulate human mesenchymal stromal senescence and acute myeloid leukemia cell proliferation through repressing transcription of MCP-1.
Leukemia-Lymphoma, Adult T-Cell
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Leukocytosis
Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-?B and p38 MAPK.
Tobacco smoking and acute exercise on immune-inflammatory responses among relative short and longer smoking histories.
Leukoencephalopathies
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Leukoencephalopathy, Progressive Multifocal
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Lichen Planus
MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions.
Lichen Planus, Oral
An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus.
Listeriosis
IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.
LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation.
Neutrophils sequestered in the liver suppress the proinflammatory response of Kupffer cells to systemic bacterial infection.
Liver Cirrhosis
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.
Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice.
Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide.
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice.
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
The role of monocyte chemoattractant protein-1 in biliary atresia.
The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Liver Cirrhosis, Alcoholic
Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis.
Liver Diseases
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.
CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Diagnostic and Prognostic Values of Monocyte Chemotactic Protein-1 in Ascitic Fluid of Patients with Spontaneous Bacterial Peritonitis.
Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery.
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Sphingosine 1-phosphate/microRNA-1249-5p/MCP-1 axis is involved in macrophage-associated inflammation in fatty liver injury in mice.
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Liver Diseases, Alcoholic
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Hepatocyte-specific hypoxia-inducible factor-1? is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Increased monocyte MCP-1 production in acute alcoholic hepatitis.
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Liver Failure, Acute
MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: A pilot study.
Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease.
Secreted Ectodomain of SIGLEC-9 and MCP-1 Synergistically Improve Acute Liver Failure in Rats by Altering Macrophage Polarity.
Liver Neoplasms
Correlation between inflammatory cytokines and liver cancer stem cell markers in DEN-induced liver cancer rats.
Liver Neoplasms, Experimental
Cachexia--induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease.
Lung Diseases
Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells.
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.
In vivo hydroquinone exposure impairs MCP-1 secretion and monocyte recruitment into the inflamed lung.
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants.
Lung Diseases, Interstitial
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia.
[Relationship between the level of MCP-1 expression in sera of RA patients and ILD]
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Lung Injury
A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1.
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.
Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1.
Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis.
Brain death-induced lung injury is complement dependent, with a primary role for the classical/lectin pathway.
Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-?B activation and oxidative stress mediators.
CD38 deficiency up-regulated IL-1? and MCP-1 through TLR4/ERK/NF-?B pathway in sepsis pulmonary injury.
Chemokine Involvement in Lung Injury Secondary to Ischaemia/Reperfusion.
Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease.
Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models.
Divergent Effects of Neutrophils on Fas-Induced Pulmonary Inflammation, Apoptosis, and Lung Damage.
Effect of acetazolamide on cytokines in rats exposed to high altitude.
Effect of acute inflammatory lung injury on the expression of monocyte chemoattractant protein-1 (MCP-1) in rat pulmonary alveolar macrophages.
Effect of dexmedetomidine on lung ischemia?reperfusion injury.
Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury.
Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP.
Immunity-Related Protein Expression and Pathological Lung Damage in Mice Poststimulation with Ambient Particulate Matter from Live Bird Markets.
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Intraperitoneal blood exacerbates the remote inflammatory response to murine peritonitis.
Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1.
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2.
Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C).
PDX regulates inflammatory cell infiltration via resident macrophage in LPS-induced lung injury.
Pivotal Role of 5-Lipoxygenase Pathway in Lung Injury After Experimental Sepsis.
Protein kinase C modulates the pulmonary inflammatory response in acute pancreatitis.
Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black.
Rat donor lung quality deteriorates more after fast than slow brain death induction.
Recovery from oxidant-mediated lung injury: response of metallothionein, MIP-2, and MCP-1 to nitrogen dioxide, oxygen, and ozone exposures.
Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta.
Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats.
San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs.
Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
[Protective effect of early intervention with lipoxin A4 on septic mice].
Lung Neoplasms
?-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-?B/HIF-1? signaling pathway.
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.
Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance.
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-?B and inhibition of monocyte chemoattractant protein-1 in urethane induced lung tumor model.
Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases.
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-?B signaling pathway.
Lung Cancer Cell-Derived Secretome Mediates Paraneoplastic Inflammation and Fibrosis in Kidney in Mice.
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China.
Relationship between genetic polymorphisms in MCP-1, CCR-2, and non-small-cell lung cancer in the Han nationality of Northern China.
The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Lupus Erythematosus, Systemic
A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients.
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells.
Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.
Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus.
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
[Expression of monocyte chemoattractant protein-1 and lupus nephritis]
Lupus Nephritis
Absence of association between the MCP-1 gene polymorphism and histological phenotype of lupus nephritis.
Analysis of urinary TGF-?1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis.
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis.
Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
Correlations of Urinary Biomarkers, TNF-Like Weak Inducer of Apoptosis (TWEAK), Osteoprotegerin (OPG), Monocyte Chemoattractant Protein-1 (MCP-1), and IL-8 with Lupus Nephritis.
Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study.
The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Mediates p38 Mitogen-Activated Protein Kinase Activation and Signal Transduction in Peripheral Blood Mononuclear Cells from Patients with Lupus Nephritis.
Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis.
Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Urinary TWEAK and the activity of lupus nephritis.
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
Lupus Vasculitis, Central Nervous System
Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
Lyme Disease
Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro.
Lymphatic Metastasis
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Lymphedema
Inflammation Precedes Fat Deposition in an Experimental Model of Lymphedema.
Lymphocytosis
Mediators of hypersensitivity pneumonitis.
Lymphoma
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma.
Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.
Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1.
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Lymphoma, B-Cell
Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer's disease-induced in ovarictomized rats.
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma.
Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Lymphoma, Follicular
MCP-1 modulates chemotaxis by follicular lymphoma cells.
Lymphoma, Large B-Cell, Diffuse
Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma.
Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937.
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Lymphoma, Non-Hodgkin
Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells.
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Lymphoma, T-Cell
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Lymphopenia
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Macular Degeneration
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration.
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD).
Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration.
Macular Edema
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration.
Serum inflammatory markers in diabetic retinopathy.
Malaria
Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2.
Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain.
Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria.
Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.
Events associated with susceptibility to invasive Salmonella enterica serovar Typhi in BALB/c mice previously infected with Plasmodium berghei ANKA.
Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand.
Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
Malaria, Cerebral
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.
Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand.
Malaria, Vivax
Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region.
Malnutrition
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Mastocytoma
Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.
Measles
Induction of beta-family chemokines mRNA in human embryonic astrocytes by inflammatory cytokines and measles virus protein.
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Melanoma
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
An Autocrine Wnt5a Loop Promotes NF-?B Pathway Activation and Cytokine/Chemokine Secretion in Melanoma.
Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.
Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
Endogenous PGE(2) induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma.
Expression of monocyte chemotactic protein-1 in human melanoma in vivo.
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Inhibition of proliferation and migration of melanoma cells by ketoconazole and Ganoderma immunomodulatory proteins.
INTRAOCULAR ACTIVATION OF ANGIOGENIC AND INFLAMMATORY PATHWAYS IN UVEAL MELANOMA.
Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice.
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.
Measurement of 45 cytokine, chemokine and growth factors in established cell culture supernatants and autologous serum from advanced melanoma patients.
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice.
Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis.
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.
Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme.
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
Melanoma, Experimental
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Melioidosis
Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.
Meningioma
Expression of monocyte chemoattractant protein-1 in meningioma.
Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells and monocytes in meningioma.
Meningitis
Chemokine patterns in meningococcal disease.
Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.
Chemokines in the cerebrospinal fluid of patients with meningitis.
Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.
Meningitis, Bacterial
Chemokines and chemotaxis of leukocytes in infectious meningitis.
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Meningitis, Cryptococcal
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Meningitis, Pneumococcal
Myeloid-Related Protein 8/14 Participates in the Progression of Experimental Pneumococcal Meningitis by Augmentation of Inflammation.
Meningitis, Viral
Chemokines and chemotaxis of leukocytes in infectious meningitis.
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1.
Meningococcal Infections
Chemokine patterns in meningococcal disease.
Meningoencephalitis
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.
Mesothelioma
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Metabolic Diseases
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Metabolic Syndrome
Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study.
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients.
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome.
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects.
Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention.
Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease.
Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome.
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
Phytochemical characterization of Tabernanthe iboga root bark and its effects on dysfunctional metabolism and cognitive performance in high-fat-fed C57BL/6J mice.
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.
The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.
Therapeutic Lifestyle Modification Program Reduces Plasma Levels of the Chemokines CRP and MCP-1 inSubjects With Metabolic Syndrome.
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
[Left ventricular mass, forced baseline spirometry and adipocytokine profiles in obese children with and without metabolic syndrome.]
Microcephaly
Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week.
Microvascular Angina
Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X?
Migraine Disorders
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Possible association between dysfunction of vitamin D binding protein (GC Globulin) and migraine attacks.
Migraine with Aura
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Miller Fisher Syndrome
Detection of MCP-1 and IL-8 in the serum and cerebrospinal fluid of a child with Miller Fisher syndrome.
Mouth Diseases
Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.
Mouth Neoplasms
Anti-IL-20 monoclonal antibody alleviates inflammation in oral cancer and suppresses tumor growth.
CCR2-64I gene polymorphism increase susceptibility to oral cancer.
Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
[Investigation of the effect of nuclear factor ?B on inflammatory cell recruitment phenotype of oral cancer associated macrophage].
Movement Disorders
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation.
Mucocutaneous Lymph Node Syndrome
Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.
Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
Mucositis
Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis.
Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liver.
Multiple Myeloma
Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
Multiple Sclerosis
CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).
Decreased CD14+CCR2+ monocytes in active multiple sclerosis.
Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease.
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.
Rational design of CCR2 antagonists: a survey of computational studies.
Role of MCP-1 and CCR2 in alcohol neurotoxicity.
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies.
Targeting monocyte chemoattractant protein-1 signalling in disease.
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.
[Chemokines as mediators for intercellular communication in the brain]
[Chemokines MIP-1 and MCP-1 and patients with multiple sclerosis treated with interferon beta-1a]
Multiple Sclerosis, Relapsing-Remitting
Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis.
Muscle Weakness
Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.
Muscular Atrophy
Local Cyclical Compression Modulates Macrophage Function In Situ and Alleviates Immobilization-Induced Muscle Atrophy.
Muscular Diseases
Expression of leukocyte chemotactic cytokines in myocardial tissue.
Musculoskeletal Pain
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Myalgia
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Myasthenia Gravis, Autoimmune, Experimental
Chemokine production by rat myocytes exposed to interferon-gamma.
Myocardial Infarction
Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Chemokines and left ventricular function in patients with acute myocardial infarction.
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.
Clinical diagnostic value of combined detection of IMA, D-D and MCP-1 in acute myocardial infarction.
Coronary collaterals: the role of MCP-1 during the early phase of acute myocardial infarction.
Dobutamine inhibits monocyte chemoattractant protein-1 production and chemotaxis in human monocytes.
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size.
Inflammation and coronary artery disease.
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
MiR-124 Regulates the Inflammation and Apoptosis in Myocardial Infarction Rats by Targeting STAT3.
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium.
Monocyte chemoattractant protein-1 and coronary artery disease.
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.
Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction.
Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction.
Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population.
The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population.
Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
[Temporal changes and interaction of serum cytokines in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention].
Myocardial Ischemia
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Blockade of the monocyte chemoattractant protein-1 receptor pathway ameliorates myocardial injury in animal models of ischemia and reperfusion.
Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.
MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects.
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70.
The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.
The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population.
[Prospects of buccal epithelium application for noninvasive diagnosis of coronary heart disease in people of different age.]
Myocarditis
Coxsackievirus b3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.
Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.
Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1.
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Interleukin-17-induced expression of monocyte chemoattractant protein-1 in cardiac myocytes requires nuclear factor ?B through the phosphorylation of p65.
Kruppel-like factor 10 protects against acute viral myocarditis by negatively regulating cardiac MCP-1 expression.
Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimental autoimmune myocarditis in rats.
Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux.
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Myoma
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
Myositis
Clinical Features and Cytokine Profile in Myositis Patients with Anti-EJ Autoantibodies Detected by a Novel Immunoprecipitation Assay.
Differential expression of chemokines in inflammatory myopathies.
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Myositis, Inclusion Body
Differential expression of chemokines in inflammatory myopathies.
Myxoma
Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
Narcolepsy
Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: A case-control study.
Nasal Polyps
IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies.
[Expression of monocyte chemotactic protein 1 and vascular endothelial growth factor in nasal polyps]
Nasopharyngeal Carcinoma
Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma.
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
Nematode Infections
Disruption of CD40-CD40 ligand pathway inhibits the development of intestinal muscle hypercontractility and protective immunity in nematode infection.
Neoplasm Metastasis
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Activation of the NF-¿B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Appearance of peanut agglutinin in the blood circulation after peanut ingestion promotes endothelial secretion of metastasis-promoting cytokines.
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Cytokine Production by Tumor Bioptate at Different Pathological Prognostic Stages in Breast Cancer.
Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases.
Determination of angiogenic factors in serum by protein array in patients with renal cell carcinoma.
Effects of protein kinase Cdelta and phospholipase C-gamma1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death.
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model.
TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts.
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
Neoplasm Micrometastasis
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Neoplasms
5-Fluoruracil blocked giant cell tumor progression by suppressing osteoclastogenesis through NF-kappaB signals and blocking angiogenesis.
9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages.
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.
A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.
A metalloporphyrin antioxidant alters cytokine responses after irradiation in a prostate tumor model.
A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells.
Abciximab combined with half-dose reteplase has beneficial effects on inflammatory myocardial response in patients with myocardial infarction.
Ablation of Galectin-12 Inhibits Atherosclerosis through Enhancement of M2 Macrophage Polarization.
Absence of Glia Maturation Factor Protects Dopaminergic Neurons and Improves Motor Behavior in Mouse Model of Parkinsonism.
AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma.
Acidic stress-ER stress axis for blunted activation of NF-?B in mesothelial cells exposed to peritoneal dialysis fluid.
Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat.
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Activation of the NF-¿B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Activation PDGFR-?/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin.
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.
Adipose tissue IL-8 is increased in normal weight women after menopause and reduced after gastric bypass surgery in obese women.
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
Age-Associated Proinflammatory Secretory Phenotype in Vascular Smooth Muscle Cells From the Non-human Primate Macaca mulatta: Reversal by Resveratrol Treatment.
Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice.
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
Airway mucosal immune-suppression in neonates of mothers receiving A(H1N1)pnd09 vaccination during pregnancy.
Almond Skin Polyphenol Extract Inhibits Inflammation and Promotes Lipolysis in Differentiated 3T3-L1 Adipocytes.
Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer's disease-induced in ovarictomized rats.
Alteration in the responsiveness to tumour necrosis factor-alpha is crucial for maximal expression of monocyte chemoattractant protein-1 in human neutrophils.
Alteration of a macrophages inflammatory protein-related protein-2 (MRP-2) response by high fat and cholesterol diet in mice.
Altered adhesive properties of cord blood endothelial outgrowth cells expressing IL-1ra.
Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.
Aluminium, carbonyls and cytokines in human nipple aspirate fluids: Possible relationship between inflammation, oxidative stress and breast cancer microenvironment.
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
An aqueous extract of Nomura's jellyfish ameliorates inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells and a zebrafish model of inflammation.
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.
An overview on Vadimezan (DMXAA): The vascular disrupting agent.
Androgen-androgen receptor system improves chronic inflammatory conditions by suppressing monocyte chemoattractant protein-1 gene expression in adipocytes via transcriptional regulation.
Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
Anti-chemokine therapy for inflammatory diseases.
Anti-Folate Receptor-? IgE but not IgG Recruits Macrophages to Attack Tumors via TNF?/MCP-1 Signaling.
Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.
Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib.
Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes.
Appearance of peanut agglutinin in the blood circulation after peanut ingestion promotes endothelial secretion of metastasis-promoting cytokines.
Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.
Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients.
Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.
Association of endocannabinoids with pain in endometriosis.
Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy.
Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma.
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: A meta-analysis.
Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light-breed horses.
Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India.
Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.
Astragalus polysaccharide induces anti-inflammatory effects dependent on AMPK activity in palmitate-treated RAW264.7 cells.
ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile.
Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.
Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice.
Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis.
Berry anthocyanins as novel antioxidants in human health and disease prevention.
Biomarkers for systemic lupus erythematosus.
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota-A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells.
Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients.
Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma.
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.
Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype.
Carvedilol prevents pancreatic ?-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-?B, COX-2, iNOS and oxidative stress.
Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1.
CC chemokine receptor-2A is frequently overexpressed in glioblastoma.
Cecum ligation and dissection: a novel modified mouse sepsis model.
Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Cerebrospinal fluid IL-6, TNF-? and MCP-1 in children with acute lymphoblastic leukaemia during chemotherapy.
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection.
Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines.
Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression.
Chemokines in multiple myeloma.
Chemokines, osteopontin, ICAM-1 gene expression in cultured rat mesangial cells.
Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer.
Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients.
Coadministration of the cyanobacterial lipopolysaccharide antagonist CyP with antibiotic inhibits cytokine production by an in vitro meningitis model infected with Neisseria meningitidis.
Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance.
Comparative study of cytokine content in the plasma and wound exudate from children with severe burns.
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli.
Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees.
Control of chemokine production at the blood-retina barrier.
Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro.
Correlations between Tear Cytokines, Chemokines, and Soluble Receptors and Clinical Severity of Dry Eye Disease.
COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
CuII(atsm) Attenuates Neuroinflammation.
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Curcumin affects ox-LDL-induced IL-6, TNF-?, MCP-1 secretion and cholesterol efflux in THP-1 cells by suppressing the TLR4/NF-?B/miR33a signaling pathway.
Curcumin blocks activation of pancreatic stellate cells.
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Cytokine Production by Tumor Bioptate at Different Pathological Prognostic Stages in Breast Cancer.
Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes.
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies.
Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts.
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.
Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation.
Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
Cytokines as targets in chronic obstructive pulmonary disease.
Cytokines in various molecular subtypes of breast cancer.
Cytokines, chemokines, and cytokine receptors in human microglia.
Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.
Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells.
Decellularization protocol-dependent damage-associated molecular patterns in rat uterus scaffolds differentially affect the immune response after transplantation.
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Deficiency of ??T cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-?B and inhibition of monocyte chemoattractant protein-1 in urethane induced lung tumor model.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Dextromethorphan - A widely-used cough suppressant - Induces local anaphylaxis via MRGPRX2 on mast cells.
Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation.
Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.
Dietary energy balance modulates ovarian cancer progression and metastasis.
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors.
Differential effects of staurosporine and its analogues on chemokine release by promyelocytic leukemia cell line NB-4.
Differential Immune Activating, Anti-Inflammatory, and Regenerative Properties of the Aqueous, Ethanol, and Solid Fractions of a Medicinal Mushroom Blend.
Differential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice.
Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice.
Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.
Direct contact between human peripheral blood mononuclear cells and renal fibroblasts facilitates the expression of monocyte chemoattractant protein-1.
Divergent cytokine response following maximum progressive swimming in hot water.
Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.
Early and late neuropathological features of meningoencephalitis associated with Maraba virus infection.
Early Inflammatory Reactions in Atherosclerosis Are Induced by Tyrosine Kinase Proline-Rich Tyrosine Kinase/Reactive Oxygen Species-Mediated Release of Tumor Necrosis Factor-{alpha} and Subsequent Activation of the p21Cip1/Ets-1/p300 System.
Early inflammatory response in epithelial ovarian tumor cyst fluids.
Early inflammatory response in soft tissues induced by thin calcium phosphates.
Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines.
Effect of acetazolamide on cytokines in rats exposed to high altitude.
Effect of digital hypothermia on lamellar inflammatory signaling in the euglycemic hyperinsulinemic clamp laminitis model.
Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis.
Effect of High Glucose Concentration on Human Preadipocytes and Their Response to Macrophage-Conditioned Medium.
Effect of IL-1 beta and TNF-alpha on the expression of monocyte chemotactic protein-1 in endometriotic cells.
Effect of Kumatakenin Isolated From Cloves on the Apoptosis of Cancer Cells and the Alternative Activation of Tumor-Associated Macrophages.
Effect of nicotine on placental inflammation and apoptosis in preeclampsia-like model.
Effect of sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells.
Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro.
Effects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancer.
Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Effects of Voluntary Running and Soy Supplementation on Diet-Induced Metabolic Disturbance and Inflammation in Mice.
Egg-Derived Peptide IRW Inhibits TNF-?-Induced Inflammatory Response and Oxidative Stress in Endothelial Cells.
Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures.
Enforced effect of tk-MCP-1 fusion gene in ovarian cancer.
Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Enhanced antitumor immunity in mice deficient in CD69.
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice.
Enhanced tumor growth in the remaining lung after major lung resection.
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy.
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1.
Establishment of inflammatory model induced by Pseudorabies virus infection in mice.
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.
Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation.
Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
Experimental gliosarcoma induces chemokine receptor expression in rat brain.
Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma.
Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils.
Expression and regulation of the CC-chemokine monocyte chemoattractant protein-1 in rat testicular cells in primary culture.
Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis.
Expression of chemotaxis- and angiogenesis-related factors in human monocytes following interaction with colon cancer cells is suppressed by low-dose lipopolysaccharide.
Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis.
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: Involvement of ATP and P2X(7) receptor.
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X? receptor.
Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues.
Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators.
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain.
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Expression of monocyte chemoattractant protein-1 in vascular tissue.
Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes.
Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Expression of monocyte chemotactic protein-1 in human melanoma in vivo.
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes.
FGF1 and VEGF mediated angiogenesis in KHT tumor-bearing mice.
Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells.
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells.
Gax gene transfer inhibits vascular remodeling induced by adventitial inflammation in rabbits.
Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Germinated Brown Rice Attenuates Atherosclerosis and Vascular Inflammation in Low-Density Lipoprotein Receptor-Knockout Mice.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Glucocorticoids use in kidney transplant setting.
Glucosyl Hesperidin Has an Anti-diabetic Effect in High-Fat Diet-Induced Obese Mice.
GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1 h68.
Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture.
Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells.
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Heat-Processed Scutellariae Radix Protects Hepatic Inflammation through the Amelioration of Oxidative Stress in Lipopolysaccharide-Induced Mice.
Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.
Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses.
Hepatoprotective, Antihyperlipidemic, and Anti-inflammatory Activity of Moringa oleifera in Diabetic-induced Damage in Male Wistar Rats.
High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich ascites.
High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice.
High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.
Highly oxidized low-density lipoprotein mediates activation of monocytes but does not confer interleukin-1? secretion nor interleukin-15 transpresentation function.
Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment.
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children.
Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene.
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays.
Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches.
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.
Human Truncated Tau is Using a Different Mechanism from Amyloid-beta to Damage the Blood-Brain Barrier.
Hyperglycemic Condition Causes Pro-Inflammatory and Permeability Alterations Associated with Monocyte Recruitment and Deregulated NF?B/PPAR? Pathways on Cerebral Endothelial Cells: Evidence for Polyphenols Uptake and Protective Effect.
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Hypoxia inhibits macrophage migration.
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor.
IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype.
IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.
IL-20 may contribute to the pathogenesis of human intervertebral disc herniation.
IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells.
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.
IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines.
IL-7, IL-18, MCP-1, MIP1-?, and OPG as biomarkers for pain treatment response in patients with cancer.
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.
Immolina, a high-molecular-weight polysaccharide fraction of spirulina, enhances chemokine expression in human monocytic THP-1 cells.
Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population?
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma.
Immune Mediators of Protective and Pathogenic Immune Responses in Patients with Mild and Fatal Human Monocytotropic Ehrlichiosis.
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer.
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.
Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.
Immune system modulates the function of adult neural stem cells.
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Improvement of antigen binding ability of human antibodies by light chain shifting.
In situ increased chemokine expression in human cervical intraepithelial neoplasia.
In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway.
Increase of inflammatory markers after indoor renovation activities: the LISA birth cohort study.
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Increased monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha can mediate macrophage infiltration in gliomas.
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Increased susceptibility of hyperthyroid rats to ozone: early events and mechanisms.
Induction and secretion of the chemokines interleukin-8 and monocyte chemotactic protein-1 in human immature leukemia cell lines.
Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells.
Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells.
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression.
Induction of monocyte chemoattractant protein-1 by Mycoplasma hominis in respiratory epithelial cells.
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum.
Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta.
Inflammatory cytokines as biomarkers in heart failure.
Inflammatory genes in rat livers from cardiac- and brain death donors.
Inflammatory mediators in chronic obstructive pulmonary disease.
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.
Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters.
Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries.
Inhibition of monocyte chemoattractant protein-1 by Krüppel-like factor 5 small interfering RNA in the tumor necrosis factor- alpha-activated human umbilical vein endothelial cells.
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Inhibition of proliferation and migration of melanoma cells by ketoconazole and Ganoderma immunomodulatory proteins.
Inhibitory effect of Malvidin on TNF-?-induced inflammatory response in endothelial cells.
Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts.
Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells.
Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Inhibitory Effects of ?-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.
Initial characterization of the carbohydrate structure of MCP-1.
Innate immune molecule surfactant protein D attenuates sepsis-induced acute kidney injury through modulating apoptosis and NF?B-mediated inflammation.
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.
Interaction of differentiated human adipocytes with macrophages leads to trogocytosis and selective IL-6 secretion.
Interference with MCP-1 gene expression by vector generated triple helix-forming RNA oligonucleotides.
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells.
Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts.
Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells.
Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.
Interleukin-8 secretion of cortical tubular epithelial cells is directed to the basolateral environment and is not enhanced by apical exposure to Escherichia coli.
Intra-amniotic LPS modulates expression of antimicrobial peptides in the fetal sheep lung.
INTRAOCULAR ACTIVATION OF ANGIOGENIC AND INFLAMMATORY PATHWAYS IN UVEAL MELANOMA.
Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis.
Intratumoral VEGF and FGF1 administration alters tumor growth, vascular density, oxygenation, and expression of MCP-1 and interleukins.
Ischemic Stroke May Activate Bone Marrow Mononuclear Cells to Enhance Recovery After Stroke.
JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-?B signaling pathway.
Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).
Knockout of ccr2 alleviates photoreceptor cell death in a model of retinitis pigmentosa.
Laminar Inflammation Responses in the Oligofructose Overload Induced Model of Bovine Laminitis.
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).
Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.
Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimental autoimmune myocarditis in rats.
Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer.
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways.
Localized immunosuppressive environment in the foreign body response to implanted biomaterials.
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.
Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.
Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NF?B-TLR signaling pathway.
Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells.
Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma.
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
Mammary tumors suppress aging-induced neuroinflammation in female Balb/c mice.
Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease.
Mast cells and chemokines.
MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.
MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression.
MCP-1 modulates chemotaxis by follicular lymphoma cells.
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1? in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis.
MCP-1: chemoattractant with a role beyond immunity: a review.
MCP-1: Function, regulation, and involvement in disease.
Measurement of CD4+ and CD8+ T-Lymphocyte Cytokine Secretion and Gene Expression Changes in p-Phenylenediamine Allergic Patients and Tolerant Individuals.
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation.
Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.
Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
Metastatic breast cancer induces an osteoblast inflammatory response.
miR-218 regulates diabetic nephropathy via targeting IKK-? and modulating NK-?B-mediated inflammation.
Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model.
Mitochondrial reactive oxygen species regulate fungal protease-induced inflammatory responses.
Modeling the inhibition of breast cancer growth by GM-CSF.
Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine.
Modulation of Toll-like receptor-mediated innate immunity in bovine intestinal epithelial cells by lactic acid bacteria isolated from feedlot cattle.
Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells.
Molecular basis of lateral force spectroscopy nano-diagnostics: computational unbinding of autism related chemokine MCP-1 from IgG antibody.
Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines.
Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
Monitoring the treatment efficacy of the vascular disrupting agent CA4P.
Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease.
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Monocyte chemoattractant protein production in red cell incompatibility.
Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung.
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Monocyte Chemoattractant Protein-1 and Large Artery Structure and Function in Young Individuals: The African-PREDICT Study.
Monocyte chemoattractant protein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis.
Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes.
Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas.
Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Monocyte Chemoattractant Protein-1 in Dogs Affected with Neoplasia or Inflammation.
Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.
Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16 week, double-blind randomized clinical trial.
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Monocyte chemoattractant protein-1 stimulates tumor necrosis and recruitment of macrophages into tumors in tumor-bearing nude mice: increased granulocyte and macrophage progenitors in murine bone marrow.
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells.
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.
Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2.
Monocyte chemotactic proteins from human tumor cells.
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia.
Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.
Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.
Mouse interleukin-20 receptor 1a targets renal epithelial cells and is associated with renal calcium deposition.
Multiorgan procurement increases systemic inflammation in brain dead donors.
Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology.
Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells.
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells.
Myeloma light chain-induced renal injury in mice.
n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-?B-dependent mechanisms.
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity.
Neurotensin and the neurotensin receptor-3 in microglial cells.
NF-?Bp65 and Expression of Its Pro-Inflammatory Target Genes Are Upregulated in the Subcutaneous Adipose Tissue of Cachectic Cancer Patients.
No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Nutrition and cancer prevention.
Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes.
Oestrogen receptor negative breast cancers exhibit high cytokine content.
Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation.
Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-alpha and interferon-gamma.
ORAL ASTAXANTHIN SUPPLEMENTATION PREVENTS PERITONEAL FIBROSIS IN RATS.
Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-?1.
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk.
Pathobiology of atherosclerosis--a brief review.
Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM).
PDGF-BB enhances monocyte chemoattractant protein-1 mRNA stability in smooth muscle cells by downregulating ribonuclease activity.
Pentraxin-3 regulates the inflammatory activity of macrophages.
Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Peroxisome proliferator-activated receptor gamma coactivator-1?/HSF1 axis effectively alleviates lipopolysaccharide-induced acute lung injury via suppressing oxidative stress and inflammatory response.
Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Pituitary Adenylate Cyclase-Activating Polypeptide Deficiency Enhances Oxazolone-Induced Allergic Contact Dermatitis in Mice.
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension.
Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Prevention of colitis-associated colorectal cancer with 8-hydroxydeoxyguanosine.
Prevention of liver cirrhosis in rats by curcumin.
Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase.
Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells.
Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions.
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.
Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells.
Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells.
Production of monocyte chemotactic protein-1 by rat brain macrophages.
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma.
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Proinflammatory effects of advanced lipoxidation end products in monocytes.
Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro.
Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an m1 phenotype in retinal microglia.
Protective Effects of Geniposide on Hepatic Ischemia/Reperfusion Injury.
Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.
Protective role of Akt2 in Salmonella enterica serovar typhimurium-induced gastroenterocolitis.
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation.
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.
Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus.
Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines.
Regulation of cytokine expression by Schwann cells in response to ?2-macroglobulin binding to LRP1.
Regulation of Granulocyte Colony-Stimulating Factor and Its Receptor in Skeletal Muscle is Dependent Upon the Type of Inflammatory Stimulus.
Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue.
Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells.
Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta.
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer.
Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines.
Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines.
Regulatory feedback loop between NF-kappaB and MCP-1-induced protein 1 RNase.
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Relationship between MCP1 (-2518A>G) gene variants and ovarian cancer in Turkish population.
Relationship between the Monocyte Chemo-attractant Protein-1 gene rs1024611 A>G Polymorphism and Cancer Susceptibility: A Meta-analysis Involving 14,617 Subjects.
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women.
Release of endogenous heat shock protein 72 on the survival of sepsis in rats.
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Renoprotective Effect of Oridonin in a Mouse Model of Acute Kidney Injury via Suppression of Macrophage Involved Inflammation.
Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity.
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.
Response of VEGF to activation of viral receptors and TNF? in human mesangial cells.
Retinal neuronal MCP-1 induced by AGEs stimulates TNF-? expression in rat microglia via p38, ERK, and NF-?B pathways.
Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.
Rho-kinase mediates TNF-?-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.
RhoA induces expression of inflammatory cytokine in adipocytes.
Role of mast cells in atherosclerosis: a classical inflammatory disease.
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction.
Roles of omental and bone marrow adipocytes in tumor biology.
Second hand smoke stimulates tumor angiogenesis and growth.
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Serum amyloid P and a DC-SIGN ligand inhibit high fat diet-induced adipose tissue and liver inflammation and steatosis in mice.
Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.
Serum Inflammatory Factor Profiles in the Pathogenesis of High-Altitude Polycythemia and Mechanisms of Acclimation to High Altitudes.
Serum monocyte chemoattractant protein-1 in pancreatic cancer.
Serum monocyte chemoattractant protein-1 in patients with postoperative infectious complications from gastrointestinal surgery for cancer.
Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.
Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential.
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Size matters: TLR4-mediated effects of ?-(1,5)-linear arabino-oligosaccharides in macrophage-like cells depend on their degree of polymerization.
Social isolation stress facilitates chemically induced oral carcinogenesis.
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor.
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
Standard versus video-assisted thyroidectomy: objective postoperative pain evaluation.
Staphylococcal enterotoxin M induced inflammation and impairment of bovine mammary epithelial cells.
Statins' Withdrawal Induces Atherosclerotic Plaque Destabilization in Animal Model-A "Rebound" Stimulation of Inflammation.
Statistical prediction of the type of gastric aspiration lung injury based on early cytokine/chemokine profiles.
Stimulation through CD40 on mouse and human renal cell carcinomas triggers cytokine production, leukocyte recruitment, and antitumor responses that can be independent of host CD40 expression.
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response.
Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells and monocytes in meningioma.
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.
Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid.
Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines.
Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.
Targeting Adipokines in Obesity-Related Tumors.
Targeting astrocyte signaling for chronic pain.
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.
Tec kinases regulate actin assembly and cytokine expression in LPS-stimulated human neutrophils via JNK activation.
Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-{gamma} in Macrophages.
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Thalidomide Controls Adipose Tissue Inflammation Associated with High-Fat Diet-Induced Obesity in Mice.
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: a meta-analysis.
The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants.
The CCR2/MCP-1 Chemokine Pathway and Lung Adenocarcinoma.
The Chemical Composition of Brazilian Green Propolis and Its Protective Effects on Mouse Aortic Endothelial Cells against Inflammatory Injury.
The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
The effect of COX-2 inhibitor, nimesulide, on angiogenetic factors in primary endometrial carcinoma cell culture.
The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.
The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines.
The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
The Inflammatory CXC Chemokines, GRO?
The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.
The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth.
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.
The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma.
The role of cytokines in the immune response to influenza A virus infection.
The Role of Macrophages in the Biological Reaction to Wear Debris from Artificial Joints.
The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.
The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis.
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model.
The transcriptional factor PREB mediates MCP-1 transcription induced by cytokines in human vascular endothelial cells.
Therapeutic effects of serum extracellular vesicles in liver fibrosis.
Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.
Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells.
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients.
TNF-alpha stimulation of MCP-1 expression is mediated by the Akt/PKB signal transduction pathway in vascular endothelial cells.
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen.
trans-Retinoic acid blocks platelet-derived growth factor-BB-induced expression of the murine monocyte chemoattractant-1 gene by blocking the assembly of a promoter proximal Sp1 binding site.
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.
Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1.
Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1.
Tumor microenvironments direct the recruitment and expansion of human Th17 cells.
Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1.
Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment.
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.
Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.
Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors.
Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
USF1 promotes the development of knee osteoarthritis by activating the NF-?B signaling pathway.
Uterine chemokines in reproductive physiology and pathology.
Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.
Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.
Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis.
Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.
Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus.
Yin zi huang, an injectable multicomponent chinese herbal medicine, is a potent inhibitor of T-cell activation.
Yin-yang effect of tumour cells in breast cancer: from mechanism of crosstalk between tumour-associated macrophages and cancer-associated adipocytes.
Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
[Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)]
[Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].
[Chemokines and tumors]
[Determination of monocyte chemotactic protein-1 in cultured endometriotic cells]
[Expression of MCP-1 in airway of rats with COPD]
[Ginger extracts improve renal injury of high fructose-fed SD rats by inhibiting the expression of proinflammatory cytokines].
[Perioperative immunologic changes in colorectal cancer patients].
[Role of MCP-1 chemokine in the response of monocytes of patients with superficial tumors of the bladder treated with BCG immunotherapy]
[Study of the mechanism of mast cell increase in cellular leiomyoma of uterus]
Nephritis
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.
Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis.
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice.
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.
Oxidative DNA and mitochondrial DNA change in patients with SLE.
Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.
Relationship between MCP-1 promoter -2518 A/G gene polymorphism (rs1024611) and systemic lupus erythematosus/lupus nephritis.
Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis.
Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis.
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
Urinary biomarkers in lupus nephritis.
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
[Effects of bushen huoxue recipe on urinary levels of albumin, IL-6, TGF-beta1 and MCP-1 in chronic nephritis patients of shen-deficiency blood-stasis syndrome].
Nephritis, Interstitial
1,25-dihydroxyvitamin D3 differentially regulates IL-1alpha-stimulated IL-8 and MCP-1 mRNA expression and chemokine secretion by human primary proximal tubular epithelial cells.
Chemokine expression in experimental tubulointerstitial nephritis.
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
Nephrolithiasis
Calcium oxalate monohydrate crystals stimulate monocyte chemoattractant protein-1 and transforming growth factor ?1 expression in human renal epithelial cells.
Experimentally induced hyperoxaluria in MCP-1 null mice.
Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.
Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.
Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo.
Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells.
Urinary MCP-1?HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.
Nephrosclerosis
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
Nephrosis
Chemokine expression in experimental tubulointerstitial nephritis.
Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome.
Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
Transient and sequential expression of chemokine mRNA in glomeruli in puromycin aminonucleoside nephrosis.
Nephrosis, Lipoid
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Nephrotic Syndrome
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
[The role of Cubilin in albumin-induced MCP-1, RANTES expression by renal tubular epithelial cells]
[Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]
Nervous System Diseases
Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
Neuralgia
Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression in TNF-? induced Astrocytes Through AMPK Pathway.
Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain.
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia.
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury.
Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury.
Neuritis
Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Neuritis, Autoimmune, Experimental
Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Neurocysticercosis
CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response.
Neurodegenerative Diseases
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
[Chemokines as mediators for intercellular communication in the brain]
Neuroectodermal Tumors, Primitive
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Neurogenic Inflammation
Role of substance P and calcitonin gene-related peptide in the regulation of interleukin-8 and monocyte chemotactic protein-1 expression in human dental pulp.
Neuroinflammatory Diseases
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion.
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's disease.
Chemokines regulate the migration of neural progenitors to sites of neuroinflammation.
Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte.
Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
MCP-1: Function, regulation, and involvement in disease.
Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain".
Neuroinflammatory Markers in the Serum of Prepubertal Children with Down Syndrome.
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.
P7C3 Suppresses Neuroinflammation and Protects Retinal Ganglion Cells of Rats from Optic Nerve Crush.
Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia.
Role of MCP-1 and CCR2 in alcohol neurotoxicity.
Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain.
Stimulator of IFN genes mediates neuroinflammatory injury by suppressing AMPK signal in experimental subarachnoid hemorrhage.
Targeting monocyte chemoattractant protein-1 signalling in disease.
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
Neurologic Manifestations
Relationship between Cardiac Troponin and Thrombo-Inflammatory Molecules in Prediction of Outcome after Acute Ischemic Stroke.
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Non-alcoholic Fatty Liver Disease
Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease.
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.
Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD.
Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice.
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease.
Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice.
[Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].
[Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
Obesity
A combination of circulating chemokines as biomarkers of obesity-induced insulin resistance at puberty.
A genetic contribution to circulating cytokines and obesity in children.
Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation.
Adhesion molecules and chemokines; relation to anthropometric, body composition, biochemical and dietary variables.
Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue.
Adiponectin and pro-inflammatory cytokines in obese diabetic boys.
Adipose Tissues Characteristics of Normal, Obesity, and Type 2 Diabetes in Uygurs Population.
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes.
Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.
Arginase inhibition ameliorates adipose tissue inflammation in mice with diet-induced obesity.
Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis.
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Community-Dwelling Older Adults in Singapore.
Association of salivary C-reactive protein with the obesity measures and markers in children.
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Augmented responses to ozone in obese carboxypeptidase E-deficient mice.
Bariatric surgery improves clinical outcomes and adiposity biomarkers but not inflammatory cytokines SAA and MCP-1 after a six-month follow-up.
Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women.
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women.
Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.
Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice.
Effect of ARB on expression of CD68 and MCP-1 in adipose tissue of rats on long-term high fat diet.
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.
Effects of Voluntary Running and Soy Supplementation on Diet-Induced Metabolic Disturbance and Inflammation in Mice.
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
GLP-1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice.
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro.
High-fat diet increases the level of circulating Monocyte Chemoattractant Protein-1 in Wistar rats, independent of obesity.
Hypoxic adipocytes induce macrophages to release inflammatory cytokines that render skeletal muscle cells insulin resistant.
Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss.
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Interferon regulatory factor 7 mediates obesity-associated MCP-1 transcription.
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes.
JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Lipopolysaccharide and palmitic acid synergistically induced MCP-1 production via MAPK-meditated TLR4 signaling pathway in RAW264.7 cells.
Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.
Markers of systemic inflammation in children with hyperuricemia.
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet.
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Monocyte chemoattractant protein 1 in obesity and insulin resistance.
Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity.
Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.
Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.
Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Monocyte chemotactic protein-1 plays a role in ovarian dysfunction related to high-fat diet-induced obesity.
Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes.
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
RANTES RELEASE BY HUMAN ADIPOSE TISSUE IN VIVO AND EVIDENCE FOR DEPOT SPECIFIC DIFFERENCES.
Rational design of CCR2 antagonists: a survey of computational studies.
Resveratrol Delivery from Porous Poly(lactide-co-glycolide) Scaffolds Promotes an Anti-inflammatory Environment within Visceral Adipose Tissue.
Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity.
Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy.
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Salivary Amylase Gene Copy Number Is Associated with the Obesity and Inflammatory Markers in Children.
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Targeting MCP-1 to reduce vascular complications of obesity.
The DNA methylation of TNF-aplha, MCP-1, and adiponectin in visceral adipose tissue is related to type 2 diabetes in Xinjiang Uygur population.
The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity.
The Immunophenotyping Changes of Peripheral CD4+ T Lymphocytes and Inflammatory Markers of Class III Obesity Subjects After Laparoscopic Gastric Sleeve Surgery - A Follow-Up Study.
The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss.
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
[Effects of serum from the obesity patients with diabetic mellitus on TLR4/NF-?B pathway in human THP-1 monocytes].
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
Obesity, Abdominal
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
Obesity, Maternal
Maternal obesity and markers of inflammation in pregnancy.
Obesity, Morbid
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Maternal obesity and markers of inflammation in pregnancy.
Obstetric Labor, Premature
Blood protein profiles of infants born before 28th weeks differ by pregnancy complication.
Modulation of monocyte chemotactic protein-1 expression during lipopolysaccharide-induced preterm delivery in the pregnant mouse.
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Oligodendroglioma
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Opportunistic Infections
Blocking CXCL1-dependent neutrophil recruitment prevents immune damage and reduces pulmonary bacterial infection after inhalation injury.
Optic Nerve Diseases
Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration.
Optic Nerve Injuries
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury.
Orchitis
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in experimental autoimmune orchitis.
Osteoarthritis
Correlation between osteoarthritis and monocyte chemotactic protein-1 expression: a meta-analysis.
Elevated Synovial Fluid Concentration of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Dogs with Osteoarthritis of the Stifle.
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.
Extracellular osmolarity regulates matrix homeostasis in the intervertebral disc and articular cartilage: evolving role of TonEBP.
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis.
Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production.
Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Osteolysis
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays.
Monocyte Chemoattractant Protein 1 Expression in Synovial Fluid of Patients With Total Hip Arthroplasty.
Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles.
Osteomyelitis
Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue.
The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.
Osteonecrosis
Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation.
Osteophyte
A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats.
Osteoporosis
MCP-1 and CCR2 Gene Variants and the Risk for Osteoporosis and Osteopenia.
[Bone marrow-derived mesenchymal stem cells from estrogen deficiency induced osteoporosis mice regulate T cell migration and apoptosis through expressing MCP-1].
[Effects of ER? gene overexpression on bone mineral density and calcium and phosphorus metabolism inovariectomized osteoporosis mice].
Osteosarcoma
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Expression of different chemokines by human osteosarcoma cells in response to tumor necrosis factor-alpha.
Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Human monocyte chemotactic protein-2: cDNA cloning and regulated expression of mRNA in mesenchymal cells.
Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Possible involvement of PI3K-dependent pathways in the increased VEGF120 release from osteoblastic cells preloaded with palmitate in vitro.
Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells.
Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and ?-catenin expression and increases susceptibility to chemotherapeutic agents.
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration.
Titanium particles induce the immediate early stress responsive chemokines IL-8 and MCP-1 in osteoblasts.
Otitis
Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.
Ovarian Cysts
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Ovarian Hyperstimulation Syndrome
Inflammatory Response Patterns in ICSI Patients: A Comparative Study Between Chronic Anovulating and Normally Ovulating Women.
Ovarian Neoplasms
9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages.
Anti-Folate Receptor-? IgE but not IgG Recruits Macrophages to Attack Tumors via TNF?/MCP-1 Signaling.
Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer.
Cytokine elevations in acute coronary syndrome and ovarian cancer: a mechanism for the up-regulation of the acute phase proteins in these different disease etiologies.
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.
Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
Effect of Kumatakenin Isolated From Cloves on the Apoptosis of Cancer Cells and the Alternative Activation of Tumor-Associated Macrophages.
Functional polymorphisms in monocyte chemoattractant protein-1 are associated with increased susceptibility to ovarian cancer.
Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Hypoxia inhibits macrophage migration.
Kaempferia parviflora extract inhibits TNF-?-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-?B signaling.
MCP-1 promotes invasion and adhesion of human ovarian cancer cells.
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Oldhamianoside inhibits the growth of ovarian cancer both in vitro and in vivo via adjusting inflammation and angiogenesis signals.
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Relationship between MCP1 (-2518A>G) gene variants and ovarian cancer in Turkish population.
Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Overweight
Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus.
Associations of dietary inflammatory index, serum levels of MCP-1 and body composition in Iranian overweight and obese women: a cross-sectional study.
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NF?B.
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation.
Pro-inflammatory effect of obesity on rats with burn wounds.
Serum and follicular fluid monocyte chemotactic protein-1 levels are elevated in obese women and are associated with poorer clinical pregnancy rate after in vitro fertilization: a pilot study.
The effect of a 10-week high-intensity interval training and ginger consumption on inflammatory indices contributing to atherosclerosis in overweight women.
p-type cu2+ transporter deficiency
Production of LPS-induced inflammatory mediators in murine peritoneal macrophages: neocuproine as a broad inhibitor and ATP7A as a selective regulator.
Pancreatic Neoplasms
Serum monocyte chemoattractant protein-1 in pancreatic cancer.
Pancreatitis
Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges.
Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats.
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis.
CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro.
Clinical significance of dynamic detection for serum levels of MCP-1, TNF-? and IL-8 in patients with acute pancreatitis.
Dexamethasone down-regulates the inflammatory mediators but fails to reduce the tissue injury in the lung of acute pancreatitis rat models.
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1.
Inflammatory response on the pancreatic acinar cell injury.
Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis?
MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation.
Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome.
Obesity and the risk of severe acute pancreatitis.
Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator.
Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis.
Renaming cytokines: MCP-1, major chemokine in pancreatitis.
Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity.
Sensing of Commensal Organisms by the Intracellular Sensor NOD1 Mediates Experimental Pancreatitis.
Serum Concentration of Inflammatory Cytokines in Dogs with Suspected Acute Pancreatitis.
Substance P treatment stimulates chemokine synthesis in pancreatic acinar cells via the activation of NF-kappaB.
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis.
[Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatits: experiment with rats]
[Relationship between genetic polymorphism of MCP-1 and acute pancreatitis in Han population of Suzhou in China.]
Pancreatitis, Acute Necrotizing
[Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatits: experiment with rats]
Pancreatitis, Chronic
Alcohol modulates circulating levels of interleukin-6 and monocyte chemoattractant protein-1 in chronic pancreatitis.
Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Association between microRNA polymorphisms and chronic pancreatitis.
Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis?
Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR, and SPINK-1 in the Setting of Acute, Acute Recurrent, and Chronic Pancreatitis.
Differential expression of chemokines in normal pancreas and in chronic pancreatitis.
Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis.
The MCP-1 -2518 A/G polymorphism is not a susceptibility factor for chronic pancreatitis.
The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats.
Panuveitis
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Papillomavirus Infections
Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions.
Paralysis
MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS.
Parasitemia
Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Plasmodium genetic loci linked to host cytokine and chemokine responses.
Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure.
Parasitic Diseases
Anti-chemokine therapy for inflammatory diseases.
Chemokines in inflammatory states.
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
MCP-1 and RANTES are mediators of acute and chronic inflammation.
Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while echinococcus granulosus is strongly mediated by MCP-1, but not MIP-2.
Parathyroid Neoplasms
Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism.
Parkinson Disease
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.
Role of MCP-1 and CCR2 in alcohol neurotoxicity.
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
Parkinsonian Disorders
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
Pelvic Inflammatory Disease
Significantly Elevated Concentration of Plasma Monocyte Chemotactic Protein 1 of Patients With Pelvic Inflammatory Disease.
Penile Induration
Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.
Peri-Implantitis
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis.
Cytokine Levels and Human Herpesviruses in Saliva from Clinical Periodontal Healthy Subjects with Peri-Implantitis: A Case-Control Study.
Periapical Periodontitis
The expression of MCP-1 and CCR2 in induced rats periapical lesions.
Periodontal Diseases
Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects.
Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease.
Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease.
MIP-1? and MCP-1 as salivary biomarkers in periodontal disease.
Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels.
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Periodontitis
Anti-cardiolipin from periodontitis patients induces MCP-1 production by human umbilical vein endothelial cells.
Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts.
Chemokines in human periodontal disease tissues.
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis.
Expression profile of macrophage migration inhibitory factor in periodontitis.
Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis.
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
HIF-1? activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization.
Host Modulation in Rheumatoid Arthritis Patients with TNF Blockers Significantly Decreases Biochemical Parameters in Periodontitis.
Impact of periodontitis on chemokines in smokers.
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Increased Levels of Serum and Gingival Crevicular Fluid Monocyte Chemoattractant Protein-1 in Smokers With Periodontitis.
Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
MIP-1? and MCP-1 as salivary biomarkers in periodontal disease.
Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis.
The effect of experimental periodontitis, experimental diabetes and their combination on the serum levels of adiponectin, leptin, IL-6, IL-18, MCP-1, RANTES and sICAM-1 in rats.
The secretion of cytokines by peripheral blood mononuclear cells of patients with periodontitis and healthy controls when exposed to H2S.
Treponema denticola induces interleukin-8 and macrophage chemoattractant protein 1 production in human umbilical vein epithelial cells.
[Infiltration of monocytes/macrophages and expression of monocyte chemoattractant protein-1 in gingival tissues from patients with rapidly progressive periodontitis]
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Peripheral Arterial Disease
Association between Plasma Monocyte Chemoattractant Protein-1 Levels and the Extent of Atherosclerotic Peripheral Artery Disease.
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Peripheral Nerve Injuries
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury.
Peripheral Nervous System Diseases
Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Peritoneal Fibrosis
NFAT5 contributes to osmolality-induced MCP-1 expression in mesothelial cells.
Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.
Smad7 inhibits TGF-?1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells.
Peritonitis
5?-Reduced Glucocorticoids Exhibit Dissociated Anti-Inflammatory and Metabolic Effects.
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation.
Dietary alpha-linked galacto-oligosaccharide suppresses ovalbumin-induced allergic peritonitis in BALB/c mice.
Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages.
Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.
Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.
Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Granulocyte macrophage-colony stimulating factor stimulates secretion of chemoattractive cytokines by peritoneal macrophages of CAPD patients.
Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients.
Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis.
Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.
Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages.
MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge.
N-Acetylglucosamine Reduces Inflammatory Response during Acute Peritonitis in Uremic Rats.
Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.
Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition.
Protective effect of a novel antibody against TLR2 on zymosan-induced acute peritonitis in NF-?B transgenic mice.
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
Repositioning of the ?-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.
Synthetic 4-Hydroxy Auxarconjugatin B, a Novel Autophagy Inducer, Attenuates Gouty Inflammation by Inhibiting the NLRP3 Inflammasome.
Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1.
[Protective effect of anhydroicaritin against peritonitis in mice.]
Persistent Infection
Chronic Trypanosoma cruzi infection potentiates adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity mode.
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Treponema denticola induces interleukin-8 and macrophage chemoattractant protein 1 production in human umbilical vein epithelial cells.
plasmin deficiency
Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice.
Pleural Diseases
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Pleural Effusion
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
Tissue Plasminogen Activator Potently Stimulates Pleural Effusion via an MCP-1 Dependent Mechanism.
[Role of C-C chemokines in the determination of pleural effusion etiology]
Pleural Effusion, Malignant
Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids.
[Role of C-C chemokines in the determination of pleural effusion etiology]
Pleurisy
Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
Pneumoconiosis
Blood Levels of IL-I?, IL-6, IL-8, TNF-?, and MCP-1 in Pneumoconiosis Patients Exposed to Inorganic Dusts.
MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis.
Serum Levels of TGF-?1 and MCP-1 as Biomarkers for Progressive Coal Workers' Pneumoconiosis in Retired Coal Workers: A Three-year Follow-up Study.
Pneumonia
Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1.
Aging increases the expression of lung CINCs and MCP-1 in senile patients with pneumonia.
Antecedent acute kidney injury worsens subsequent endotoxin-induced lung inflammation in a 2-hit mouse model.
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae.
Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.
Chemokine patterns in children with acute bacterial infections.
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.
Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA.
Experimental hypersensitivity pneumonitis: role of MCP-1.
Induction of monocyte chemoattractant protein-1 (MCP-1) production by Pseudomonas nitrite reductase in human pulmonary type II epithelial-like cells.
Inhalation of welding fumes reduced sperm counts and high fat diet reduced testosterone levels; differential effects in Sprague Dawley and Brown Norway rats.
Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Latent TGF-?1 Protects Against Bleomycin-Induced Lung Injury in Mice.
Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-?B activation.
MCP-1 Antibody Treatment Enhances Damage and Impedes Repair of the Alveolar Epithelium in Influenza Pneumonitis.
Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation.
Murine TLR4 Is Implicated in Cigarette Smoke-Induced Pulmonary Inflammation.
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator.
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease.
Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP-1, CXCL10, and viral RNA in the lungs of rhesus macaques.
Tityus serrulatus scorpion venom improves survival and lung inflammation in lethal sepsis induced by CLP in mice.
[Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats]
[Effect of aging on pulmonary ICAM-1 and MCP-1 expressions in rats with lipopolysaccharide- induced acute lung injury.]
[Effect of Cryptoporus polysaccharide on lipopolysaccharide-induced production of monocyte chemoattractant protein-1 in human alveolar epithelial cells]
Pneumonia, Pneumococcal
Age-related changes in the levels and kinetics of pulmonary cytokine and chemokine responses to Streptococcuspneumoniae in mouse pneumonia models.
Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia.
Pneumoperitoneum
Immunological effects of laparoscopic and open cholecystectomy.
[Immediate peritoneal response to contamination during laparoscopic surgery in an experimental rat model.]
Polycystic Kidney Diseases
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.
PPAR? agonists in polycystic kidney disease with frequent development of cardiovascular disorders.
Renal CD14 expression correlates with the progression of cystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease.
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Co-Inheritance of Autosomal Dominant Polycystic Kidney Disease and Naevoid Basal Cell Carcinoma Syndrome: Effects on Renal Progression.
Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor ?B-induced inflammation.
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Polycystic Ovary Syndrome
Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.
Polymyalgia Rheumatica
Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.
Polymyositis
Differential expression of chemokines in inflammatory myopathies.
Polyneuropathies
Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy.
Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
Porcine Reproductive and Respiratory Syndrome
Endometriotic Mesenchymal Stem Cells Exhibit Distinct Immune-Phenotype#
Post-Cardiac Arrest Syndrome
[Dachengqi decoction reduces the serum levels of mast cell tryptase and inflammatory cytokines in rabbits with post-cardiac arrest syndrome].
Post-Traumatic Headache
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Pouchitis
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
Pre-Eclampsia
Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia.
Blood protein profiles of infants born before 28th weeks differ by pregnancy complication.
Combined use of serum MCP-1/IL-10 ratio and uterine artery Doppler index significantly improves the prediction of preeclampsia.
Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
PP028. Serum cytokine profile in relation to the clinical features and laboratory parameters in women with preeclampsia.
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia.
Thrombin impairs the angiogenic activity of extravillous trophoblast cells via monocyte chemotactic protein-1 (MCP-1): A possible link with preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Premature Birth
A MCP-1 promoter polymorphism at G-2518A is associated with spontaneous preterm birth.
Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation.
Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor.
Preventive and therapeutic effect of N-Acetyl-l-cysteine on infection-associated preterm labor in mice.
Pressure Ulcer
The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer.
Primary Graft Dysfunction
Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Primary Myelofibrosis
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.
Prion Diseases
MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease.
Prostatic Hyperplasia
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Prostatic Neoplasms
Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer.
CCR2 expression correlates with prostate cancer progression.
Elevated IL-8, TNF-?, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study.
Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles.
PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer.
Prostatitis
[Immune mechanisms of the active ingredients of Chinese medicinal herbs for chronic prostatitis].
[Influence of Kudou Shencha decotion on INF-gamma, ICAM-1, MCP-1 levels of prostate tissue homogenate in immunity prostatitis model rats].
protein-tyrosine-phosphatase deficiency
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Proteinuria
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.
Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.
Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis.
Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice.
Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Elevated plasma levels of interleukin 1 beta, tumour necrosis factor alpha and monocyte chemotactic protein 1 are associated with pregnancy toxaemia in ewes.
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Fn14 in podocytes and proteinuric kidney disease.
Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in paediatric lupus nephritis.
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
Increased Serum MCP-1 Levels in Systemic Vasculitis Patients with Renal Involvement.
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein.
Intrarenal cytokine and chemokine gene expression and kidney graft outcome.
Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells.
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis.
LPS Induces Preeclampsia-Like Phenotype in Rats and HTR8/SVneo Cells Dysfunction Through TLR4/p38 MAPK Pathway.
MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis.
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.
Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Monocyte chemoattractant protein-1 levels in patients with glomerular disease.
Nephrin and endothelial injury.
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.
Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.
RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.
Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis.
Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.
Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
Serum interferon-? and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy.
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease.
Study on the Regulation of Compound siRNA Nanoparticles on the Rat Model of Kidney Injury Induced by Sepsis by Inhibiting the Expression of NF-?B and P65.
Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats.
T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis.
Thiazide diuretics, endothelial function, and vascular oxidative stress.
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
[The role of Cubilin in albumin-induced MCP-1, RANTES expression by renal tubular epithelial cells]
[The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection]
Pruritus
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
Pseudolymphoma
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Psoriasis
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.
CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy.
Circulating levels of chemokines in patients with psoriasis vulgaris and their association with disease severity: A case-control study from North India.
Effect of NB-UVB on levels of MCP-1 and CCR6 mRNA in patients with psoriasis vulgaris.
Effect of pharmacological intervention on MIP-1?, MIP-1? and MCP-1 expression in patients with psoriasis vulgaris.
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
MCP-1 in psoriatic patients: effect of biological therapy.
MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions.
The -2518 A/G MCP-1 and -403 G/A RANTES promoter gene polymorphisms are associated with psoriasis vulgaris.
Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease.
Pterygium
The Nuclear-Factor Kappa B Pathway is Activated in Pterygium.
Pulmonary Alveolar Proteinosis
Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis.
Pulmonary Disease, Chronic Obstructive
Analysis of systemic biomarkers in COPD patients.
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
CC-chemokine receptors in chronic obstructive pulmonary disease.
Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.
Circulating monocytes from healthy individuals and COPD patients.
Comparative analysis of MCP-1 and TF in elderly patients with acute exacerbations of COPD and its clinical significance.
COPD rat model is more susceptible to cold stress and PM2.5 exposure and the underlying mechanism.
Correlation between serum biomarkers and BODE index in patients with stable COPD.
Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model.
Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs.
Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
MCP1 -2518 polymorphism and chronic obstructive pulmonary disease in Taiwanese men.
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking.
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.
Regulation of DNA methylation signatures on NF-?B and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro.
Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in COPD.
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension.
Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease.
Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
The Association of Monocyte Chemotactic Protein-1 and CC Chemokine Receptor 2 Gene Variants with Chronic Obstructive Pulmonary Disease.
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
[Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease]
[Expression of MCP-1 in airway of rats with COPD]
[The protective effects of vitamin E on lung injury caused by high temperature and PM2.5 in COPD rats].
Pulmonary Edema
Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits.
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.
Pulmonary Embolism
N-Acetylcysteine potentiates the haemodynamic-improving effect of sildenafil in a rabbit model of acute pulmonary thromboembolism via the p38 MAPK pathway.
Protective effect of breviscapine in acute pulmonary embolism rats via regulation of MCP-1 and IL-13.
[The effect of low molecular heparin and urokinase on MCP-1 of acute experimental pulmonary embolism in rabbits].
Pulmonary Eosinophilia
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.
Pulmonary Fibrosis
A role for MCP-1/CCR2 in interstitial lung disease in children.
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Elevated levels of MCP-1, MIP-alpha and MIP-1beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis.
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury.
Longitudinal micro-computed tomography-derived biomarkers quantify non-resolving lung fibrosis in a silicosis mouse model.
Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Purpura
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
Purpura, Thrombocytopenic, Idiopathic
IP-10 and MCP-1 gene polymorphisms in Chinese patients with chronic immune thrombocytopenia.
Pyelonephritis
Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.
[Proinflammatory cytokines in patients with pyelonephritis].
Q Fever
Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
Rabies
Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus.
Radiation Pneumonitis
Radiation pneumonitis and early circulatory cytokine markers.
Radicular Cyst
Cytokine and chemokine levels in radicular and residual cyst fluids.
Rectal Neoplasms
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Renal Insufficiency
Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
Monocyte adhesion molecule expression in interstitial inflammation in patients with renal failure.
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
[Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]
Renal Insufficiency, Chronic
Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.
Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.
Expression and clinical significance of MCP-1 in serum of patients with chronic kidney disease undergoing maintenance hemodialysis.
High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.
Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-?B, p53, ERK, and JNK in proximal tubular cells.
MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
Metformin inhibits TGF-beta 1-induced MCP-1 expression through BAMBI-mediated suppression of MEK/ERK1/2 signaling.
Renal TLR4 mRNA Expression Correlates with Inflammatory Marker MCP-1 and Profibrotic Molecule TGF-?(1) in Patients with Chronic Kidney Disease.
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.
Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.
Reperfusion Injury
CCR2 signaling contributes to ischemia-reperfusion injury in kidney.
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.
IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines.
Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failure.
Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.
Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.
The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer.
The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation.
Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation.
[Dynamic changes of serum MCP-1 and MIP-2 chemokines after renal transplantation in rats]
[Effect of prostaglandin E1 on monocyte chemotactic protein-1 expression in Kupffer cells of rats with hepatic ischemia-reperfusion injury]
[Effects of ischemic reperfusion on the expression of cell adhesion molecules and monocyte chemotactic protein-1 and the protective role of MgSO4]
Respiratory Distress Syndrome
High concentrations of GRO-alpha and MCP-1 in bronchoalveolar fluid of infants with respiratory distress syndrome after surfactant.
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Respiratory Insufficiency
Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome.
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review.
Retinal Detachment
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
Retinal detachment-induced Müller glial cell swelling activates TRPV4 ion channels and triggers photoreceptor death at body temperature.
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
[Effects of mechanical stress on expressions of monocyte chemoattractant protein-1 and interleukin-8 of cultured human retinal pigment epithelial cells]
Retinal Diseases
Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression.
Retinal Neovascularization
Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation.
MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.
Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization.
Retinal Perforations
Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Role of inflammation in previously untreated macular edema with branch retinal vein occlusion.
Retinal Telangiectasis
Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.
Retinal Vasculitis
Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis.
Retroviridae Infections
MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Rheumatic Fever
Rational design of CCR2 antagonists: a survey of computational studies.
Rhinitis
MCP-1, CCR2 and CCR5 Polymorphisms in Tunisian Patients with Atopic Asthma.
Rhinitis, Allergic
Cetirizine, a second-generation H1 antagonist, modulates Rantes and MCP-1 levels in allergic rhinitis.
Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa.
Rocky Mountain Spotted Fever
Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-kappaB.
Root Resorption
The role of dental pulp cells in resorption of deciduous teeth.
Sarcoidosis
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
CC and C chemokine expression in pulmonary sarcoidosis.
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia.
MCP-1 and MIP-1A gene polymorphisms in Japanese patients with sarcoidosis.
Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome.
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Sarcoidosis, Pulmonary
Chemokines in the bronchoalveolar lavage fluid of patients with sarcoidosis.
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Sarcoma
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Sarcoma, Kaposi
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.
Sarcoma, Synovial
The small molecule NSM00191 specifically represses the TNF-?/NF-?B axis in foot and ankle rheumatoid arthritis.
Sarcopenia
Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Community-Dwelling Older Adults in Singapore.
Schistosomiasis
Nitric oxide interaction with IL-10, MIP-1alpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis.
Schistosomiasis mansoni
Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation.
Scleroderma, Systemic
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis.
MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis.
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
The CTLA-4 and MCP-1 polymorphisms and susceptibility to systemic sclerosis: a meta-analysis.
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Scrub Typhus
[Differences in immune damage between patients with severe fever with thrombocytopenia syndrome and patients with tsutsugamushi disease].
Seizures
Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus.
Monocyte Chemoattractant Protein (MCP)-1 in Rotavirus-Associated White Matter Injury in Newborns.
Pre- and Postictal Changes in the Innate Immune System: Cause or Effect?
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Seizures, Febrile
Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis.
Sepsis
A Novel Role for Programmed Cell Death Receptor Ligand-1 (PD-L1) in Sepsis-Induced Intestinal Dysfunction.
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Adipocytokine Profile Reveals Resistin Forming A Prognostic-Related Cytokine Network In The Acute Phase of Sepsis.
Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis.
Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges.
Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.
Buprenorphine Markedly Elevates a Panel of Surrogate Markers in a Murine Model of Sepsis.
CD38 deficiency up-regulated IL-1? and MCP-1 through TLR4/ERK/NF-?B pathway in sepsis pulmonary injury.
Chemokine patterns in children with acute bacterial infections.
Chemokine patterns in meningococcal disease.
Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients.
Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function.
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology.
Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study.
Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.
Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.
Innate immune molecule surfactant protein D attenuates sepsis-induced acute kidney injury through modulating apoptosis and NF?B-mediated inflammation.
LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS.
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.
Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.
Pathophysiologic response to severe burn injury.
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study.
Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination.
Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era.
Role of MCP-1 in endotoxemia and sepsis.
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Sepsis Activates the TLR4/MyD88 Pathway in Schwann Cells to Promote Infiltration of Macrophages, Thereby Impeding Neuromuscular Function.
Sepsis is associated with reduced spontaneous neutrophil migration velocity in human adults.
Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs.
The clinical importance of a cytokine network in the acute phase of sepsis.
The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions.
Zymomonas mobilis culture protects against sepsis by modulating the inflammatory response, alleviating bacterial burden and suppressing splenocyte apoptosis.
[Changes in renal cell apoptosis and inflammatory cytokines in early stage of sepsis in rats.]
[Heparin inhibits lipopolysaccharide-induced adhesion of monocytes to endothelial cells].
[High mobility group box-1 stimulates proinflammatory cytokine production in endothelial cells via MAP kinases]
[Protective effect of early intervention with lipoxin A4 on septic mice].
[The effect of necrostatin-1 on expression of liver monocyte chemotactic protein-1 in septic rats].
Severe Acute Respiratory Syndrome
Future perspective: biologic agents in patients with severe COVID-19.
Severe Dengue
Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.
Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017.
Cytokine Signature Associated with Disease Severity in Dengue.
Slow resolution of inflammation in severe adult dengue patients.
Sexually Transmitted Diseases
Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: A pilot study.
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.
Shock, Cardiogenic
Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach.
Shock, Septic
Cytokine and Chemokine Profiling in Cats With Sepsis and Septic Shock.
Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function.
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression.
Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model.
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.
Prophylaxis of lipopolysaccharide-induced shock by alpha-galactosylceramide.
Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era.
Sialorrhea
Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study.
Silicosis
MCPIP1 mediates silica-induced cell migration in human pulmonary fibroblasts.
Role of human pulmonary fibroblast-derived MCP-1 in cell activation and migration in experimental silicosis.
[Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by the regulation of MCP-1 and ED-1 expression on rats with silicosis]
[The discriminant analysis of the silicosis's induction on cytokines in phlegm and combined multi-markers].
[The Function of CD40/CD40L Pathway in Silicosis Fibrosis].
Skin Diseases
Effects of Schisandra chinensis Turcz. fruit on contact dermatitis induced by dinitrofluorobenzene in mice.
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak. A review of the literature.
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin.
Sleep Apnea, Obstructive
Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.
Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome.
Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome.
[Correlation study between the levels of serum MCP-1,SAA and cognitive function in patients with COPD-OSAHS].
Sleep Initiation and Maintenance Disorders
Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
Smooth Muscle Tumor
[Study of the mechanism of mast cell increase in cellular leiomyoma of uterus]
Spinal Cord Injuries
Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat.
Effects of hyperbaric oxygen therapy on RAGE and MCP-1 expression in rats with spinal cord injury.
Involvement of glial cell line-derived neurotrophic factor in activation processes of rodent macrophages.
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
miRNA-544a Regulates the Inflammation of Spinal Cord Injury by Inhibiting the Expression of NEUROD4.
Monocyte chemoattractant protein-1 level in serum of patients with acute spinal cord injury.
Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.
Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma.
Protective Effects of SIRT6 Against Inflammation, Oxidative Stress, and Cell Apoptosis in Spinal Cord Injury.
Secreted ectodomain of sialic Acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity.
[Macrophages promote the migration of neural stem cells into mouse spinal cord injury site].
Spinal Dysraphism
Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.
Spondylitis, Ankylosing
Serum Monocyte Chemotactic Protein-1 Concentrations Distinguish Patients With Ankylosing Spondylitis From Patients With Mechanical Low Back Pain.
Squamous Cell Carcinoma of Head and Neck
An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus.
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
ST Elevation Myocardial Infarction
Abciximab combined with half-dose reteplase has beneficial effects on inflammatory myocardial response in patients with myocardial infarction.
Chemokines and left ventricular function in patients with acute myocardial infarction.
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
Kinetics of chemokines in acute myocardial infarction.
Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.
Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Staphylococcal Infections
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Starvation
[Inhibition of MCP-1 mRNA expression by propylene glycol mannate sulfate in hyperlipidemic rat aorta]
Status Epilepticus
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Still's Disease, Adult-Onset
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Stomach Neoplasms
Circulating blood levels of IL-6, IFN-?, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.
IL-1? mediates MCP-1 induction by Wnt5a in gastric cancer cells.
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Stomach Ulcer
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Stomatitis, Denture
Decreased production of proinflammatory cytokines by monocytes from individuals presenting Candida-associated denture stomatitis.
Stroke
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro.
Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes.
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke.
Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice.
Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke.
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke.
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities.
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1? and G-CSF after transient focal ischemia in mice.
Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.
Proinflammatory genetic profiles in subjects with history of ischemic stroke.
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats.
Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia.
Targeting monocyte chemoattractant protein-1 signalling in disease.
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury.
[Chemokines as mediators for intercellular communication in the brain]
Subarachnoid Hemorrhage
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage.
Surgical Wound Infection
Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery.
Synovitis
Anti-TNF-? therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
Diet-induced obesity leads to behavioral indicators of pain preceding structural joint damage in wild-type mice.
Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.
Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis.
Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
Syphilis
Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.
The immunological response to syphilis differs by HIV status; a prospective observational cohort study.
Systemic Vasculitis
Increased Serum MCP-1 Levels in Systemic Vasculitis Patients with Renal Involvement.
Tauopathies
The stress-responsive gene GDPGP1/mcp-1 regulates neuronal glycogen metabolism and survival.
Tension-Type Headache
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Thrombocytopenia
Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study.
Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE.
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
Thrombosis
15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi.
Chemokines in the pathogenesis of vascular disease.
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T.
Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi.
Monocyte recruitment in venous thrombus resolution.
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects.
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies.
Thrombolysis of deep vein thrombosis and inhibiting chemotaxis of macrophage by MCP-1 blockage.
Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
[New findings on the physiopathology of acute hemolytic transfusion reactions]
Thyroid Cancer, Papillary
The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
Thyroid Diseases
Abnormal Iodine Nutrition-Induced ER Stress Upregulates MCP-1 Expression Through P38/MAPK Signaling Pathway in Thyroid Cells.
Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Thyroiditis
Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes.
Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link?
Thyroiditis, Autoimmune
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.
Tics
Regulatory effects of Ningdong granule on microglia-mediated neuroinflammation in a rat model of Tourette's syndrome.
Tooth Loss
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Tourette Syndrome
Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases.
Transfusion Reaction
Monocyte chemoattractant protein production in red cell incompatibility.
Trichinellosis
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Trichomonas Infections
Data showing differential expression of Monocyte chemoattractant protein-1 in response to symptomatic and asymptomatic T. vaginalis infection.
Trichosporonosis
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Triple Negative Breast Neoplasms
Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity.
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Trypanosomiasis, African
Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.
Tuberculoma
Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis.
Tuberculosis
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Association of MCP-1 -2518A/G and -362G/C variants and tuberculosis susceptibility: A meta-analysis.
Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.
Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.
CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis.
Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.
Combined Analysis of IFN-?, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Early Secreted Antigenic Target of 6 kDa of Mycobacterium tuberculosis Stimulates Macrophage Chemoattractant Protein-1 Production by Macrophages and Its Regulation by p38 Mitogen-Activated Protein Kinases and Interleukin-4.
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Evaluation of the Diagnostic Efficacy of Monocyte Parameters and MCP-1 to Distinguishing Active Tuberculosis from Latent Tuberculosis.
Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis.
Genetic association meta-analysis: a new classification to assess ethnicity using the association of MCP-1 -2518 polymorphism and tuberculosis susceptibility as a model.
Impact of tuberculosis on HIV-1 replication, diversity, and disease progression.
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.
Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.
Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection.
MCP-1 -2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients.
MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis.
Mycobacterium tuberculosis Rv0652 stimulates production of TNF and MCP-1 in macrophages through the TLR4 pathway.
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Plasma Level of IL-4 Differs in Patients Infected with Different Modern Lineages of M. tuberculosis.
Production of monocyte chemoattractant protein 1 in tuberculosis patients.
Restoration of impaired free radical generation and proinflammatory cytokines by MCP-1 in mycobacterial pathogenesis.
Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-alpha, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes.
Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.
The -2518A/G Polymorphism in the MCP-1 Gene and Tuberculosis Risk: A Meta-Analysis.
The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis.
TLR stimulation of human neutrophils lead to increased release of MCP-1, MIP-1?, IL-1?, IL-8 and TNF during tuberculosis.
Tuberculosis, Pleural
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
[Study of the expression profile of immunogenesis associated genes in tuberculosis by microarray]
Tuberculosis, Pulmonary
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.
Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients.
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Genetic association meta-analysis: a new classification to assess ethnicity using the association of MCP-1 -2518 polymorphism and tuberculosis susceptibility as a model.
Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.
MCP-1 -2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients.
MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis.
MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa.
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
The association between the -2518A/G polymorphism in the MCP-1 gene and the risk of pulmonary tuberculosis in Sichuan Chinese population.
The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients.
TLR stimulation of human neutrophils lead to increased release of MCP-1, MIP-1?, IL-1?, IL-8 and TNF during tuberculosis.
[Concentration of selected cytokines associated with monocytes/macrophages in serum of patients with different clinical stages of pulmonary tuberculosis]
[The relationship between monocyte chemoattactant protein-1 gene polymorphisms and the susceptibility to pulmonary tuberculosis]
Tuberculosis, Spinal
Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population.
Monocyte chemoattractant protein-1 in spinal tuberculosis: -362G/C genetic variant and protein levels in Chinese patients.
Monocyte chemotactic protein-1 -2518 gene polymorphism and susceptibility to spinal tuberculosis.
Roles of monocyte chemotactic protein 1 and nuclear factor-?B in immune response to spinal tuberculosis in a New Zealand white rabbit model.
Tuberous Sclerosis
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Uremia
MCP-1 gene activation marks acute kidney injury.
Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.
Ureteral Obstruction
Chemokine expression in the obstructed kidney.
MCP-1 gene activation marks acute kidney injury.
The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice.
Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
Urethral Obstruction
Expression of NGF, MCP-1, uroplakin III, and NOS in bladder urothelium after partial urethral obstruction in rats.
Urinary Bladder Neoplasms
CCR2-64I is a risk factor for development of bladder cancer.
Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop.
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
Urinary Bladder, Overactive
Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder.
Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients.
Urinary Incontinence
Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder.
Urinary Tract Infections
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections.
Upper Urinary Tract Infections Are Associated with RANTES Promoter Polymorphism.
Urogenital Neoplasms
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Urticaria
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
Uterine Cervical Neoplasms
hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women.
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.
[miR-520a-3p regulates the signaling pathway of cytokine secretion in cervical cancer].
Uveitis
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
An Intraocular Inflammatory Profile of Rubella Associated Uveitis.
Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.
Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat.
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.
MCP-1 expression in endotoxin-induced uveitis.
Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.
Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits.
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Uveitis genetics.
Uveitis, Anterior
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Chemokine gene polymorphisms in idiopathic anterior uveitis.
Cytokine profile and cytoskeletal changes after herpes simplex virus type 1 infection in human trabecular meshwork cells.
Effect of berberine on monocyte chemotactic protein-1 and cytokine-induced neutrophil chemoattractant-1 expression in rat lipopolysaccharide-induced uveitis.
MCP-1 expression in endotoxin-induced uveitis.
Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells.
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
Uveomeningoencephalitic Syndrome
A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis.
Monocyte chemoattractant protein (MCP)-1 -2518 A/G SNP in Chinese Han patients with VKH syndrome.
Vaccinia
The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site.
Varicose Veins
Are Inflammatory Biomarkers Increased in Varicose Vein Blood?
Varicose Veins Show Enhanced Chemokine Expression.
Vascular Calcification
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model.
Vascular Diseases
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.
Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty.
Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Rational design of CCR2 antagonists: a survey of computational studies.
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Vascular Malformations
Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations.
Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.
Vascular System Injuries
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
Attenuation of Monocyte Chemoattractant Protein-1 Expression Via Inhibition of Nuclear Factor-kappaB Activity in Inflammatory Vascular Injury.
C-Reactive Protein Can Influence the Proliferation, Apoptosis, and Monocyte Chemotactic Protein-1 Production of Human Umbilical Vein Endothelial Cells.
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Glycemic memory associated epigenetic changes.
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury.
Interleukin-10 attenuates the response to vascular injury.
Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women.
MCP-1 contributes to arteriovenous fistula failure.
Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells.
Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Roscovitine attenuates intimal hyperplasia via inhibiting NF-?B and STAT3 activation induced by TNF-? in vascular smooth muscle cells.
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells.
Vasculitis
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.
Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis.
Levistilide A Ameliorates NLRP3 Expression Involving the Syk-p38/JNK Pathway and Peripheral Obliterans in Rats.
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis.
Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1.
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Vasospasm, Intracranial
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Potential role of poly (ADP-ribose) polymerase in delayed cerebral vasospasm following subarachnoid hemorrhage in rats.
Venous Thromboembolism
The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control study.
Venous Thrombosis
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies.
Thrombolysis of deep vein thrombosis and inhibiting chemotaxis of macrophage by MCP-1 blockage.
Ventricular Dysfunction, Left
Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Vesico-Ureteral Reflux
Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux.
Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux.
Vesicular Stomatitis
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.
Expression Kinetics of RANTES and MCP-1 in the Brain of Deer Mice (Peromyscus maniculatus) Infected with Vesicular Stomatitis New Jersey Virus.
Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes.
Viremia
Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
Virus Diseases
Age-related changes in the inflammatory responses to viral infections in the central nervous system during childhood.
Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus.
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.
HIV Neuropathogenesis: a Tight Rope Walk of Innate Immunity.
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections.
Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells.
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
The role of cytokines in the immune response to influenza A virus infection.
Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.
Zika Virus Infects Newborn Monocytes Without Triggering a Substantial Cytokine Response.
[Evaluation of soluble platelet cell adhesion molecule sPECAM-1 and chemokine MCP-1 (CCL2) concentration in CSF of patients with tick-borne encephalitis]
Vitamin D Deficiency
Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial.
Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link?
Vitreoretinopathy, Proliferative
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Vitreous Hemorrhage
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Vulvodynia
Inflammatory Markers in Vestibulodynia [4].
Whooping Cough
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells.
Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell.
G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro.
IFNgamma induces functional chemokine receptor expression in human mesangial cells.
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3.
Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity.
MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.
MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression.
MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner.
MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells.
Migration responses of human monocytic cell lines to alpha- and beta-chemokines.
Migratory Response of Human NK Cells to Monocyte-Chemotactic Proteins
Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.
Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response.
Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells.
Oestrogen exerts anti-inflammation via p38 MAPK/NF-?B cascade in adipocytes.
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice.
Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
Selective G protein coupling by C-C chemokine receptors.
Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells.
Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.
The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.
Wound Infection
Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age.
Xanthomatosis
Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice.
Yersinia Infections
Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections.